WO2020166102A1 - Liquid medicine administration device and liquid medicine administration method - Google Patents

Liquid medicine administration device and liquid medicine administration method Download PDF

Info

Publication number
WO2020166102A1
WO2020166102A1 PCT/JP2019/025685 JP2019025685W WO2020166102A1 WO 2020166102 A1 WO2020166102 A1 WO 2020166102A1 JP 2019025685 W JP2019025685 W JP 2019025685W WO 2020166102 A1 WO2020166102 A1 WO 2020166102A1
Authority
WO
WIPO (PCT)
Prior art keywords
remaining amount
alert
value
unit
drug solution
Prior art date
Application number
PCT/JP2019/025685
Other languages
French (fr)
Japanese (ja)
Inventor
勝平 佐々木
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to JP2020572069A priority Critical patent/JP7299929B2/en
Publication of WO2020166102A1 publication Critical patent/WO2020166102A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body

Definitions

  • the present invention relates to a drug administration device and a drug administration method, and more particularly to a drug administration device and a drug administration method capable of changing the drug administration method depending on the profile of a patient.
  • Patent Document 1 discloses a portable drug solution administration device that continuously or intermittently administers a drug solution filled in a cylinder into a living body under the pressing action of a plunger. Depending on the position, the contact sensor that notifies the user that the remaining amount of the drug solution in the cylinder has reached a predetermined amount is shown.
  • International publication 2016/132937 discloses a portable drug solution administration device that continuously or intermittently administers a drug solution filled in a cylinder into a living body under the pressing action of a plunger. Depending on the position, the contact sensor that notifies the user that the remaining amount of the drug solution in the cylinder has reached a predetermined amount is shown.
  • the amount of drug solution that is administered to the body there are individual differences in the amount of drug solution that is administered to the body, and for example, the amount of drug solution that is administered daily for adults and children (particularly children) is usually very different.
  • the amount of drug solution to be administered also changes depending on the patient's condition such as weekdays, exercising or illness, and meal content. Therefore, it was not appropriate to determine the predetermined amount (for example, 50 U) of the residual amount of the liquid medicine in the cylinder at the time of notifying the patient of the alert. For example, a child may use about 50 U of insulin filled in 3 days, and in this case, the alert of the remaining amount of 50 U is too early.
  • the present invention has been made in order to solve the above-described problems, and does not fix the remaining amount of the drug solution that generates an alert to a predetermined amount (for example, 50 U) from the total dose of the drug solution, and the patient situation ( It is an object of the present invention to provide a liquid medicine administration device and a liquid medicine administration method that can be changed according to the profile).
  • a predetermined amount for example, 50 U
  • the present invention is a drug solution administration device which issues a residual amount alert when the residual amount of the drug solution in the cylinder reaches a predetermined value, and the total administration of the drug solution.
  • the remaining amount value that issues a remaining amount alert from the total dose of the drug solution and outputs the remaining amount alert signal, and the remaining amount alert signal based on the remaining amount alert signal output from the calculating unit
  • a notification unit that emits. Then, when the calculated remaining amount value is equal to or larger than the predetermined value, the calculation unit outputs a remaining amount alert signal to the notification unit when the remaining amount of the chemical liquid reaches the predetermined value, and the calculated remaining amount value is the predetermined value. When it is less than, the remaining amount of the chemical liquid is counted, and when the count value reaches the calculated remaining amount value, the remaining amount alert signal is output to the notification unit.
  • the drug solution administration method of the present invention is a drug solution administration method that issues a residual amount alert when the residual amount of the drug solution in the cylinder reaches a predetermined value, and includes the following steps.
  • a step of calculating the remaining amount value of the liquid medicine which issues a remaining amount alert from the total dose of the liquid medicine by a calculation unit (B) When the remaining amount value for issuing the remaining amount alert is equal to or greater than a predetermined value, a step of outputting a remaining amount alert signal by the calculation unit when the remaining amount of the chemical liquid reaches the predetermined value, (C) When the remaining amount value for issuing the remaining amount alert is less than a predetermined value, a step of starting the counting of the remaining amount of the medical liquid by the calculation unit when the remaining amount of the medical liquid reaches the predetermined value, (D) A step of outputting a remaining amount alert signal by a computing unit when the count value reaches a remaining amount value for issuing a remaining amount alert.
  • the present invention it is possible to notify the alert of the remaining amount of the liquid medicine in the cylinder under the optimal condition of the patient in consideration of the condition of the adult, the child, or the patient.
  • FIG. 1 is an exploded perspective view of a drug solution administration device according to an embodiment of the present invention. It is a sectional view of a medical fluid administration device concerning one example of an embodiment of the present invention.
  • 6 is a display screen showing a decrease in the amount of remaining liquid medicine in the liquid medicine administration device according to the embodiment of the present invention.
  • FIG. 7 is a display screen A when changing a preset administration pattern and a display screen B when confirming and determining a basal rate pattern in the drug solution administration device according to the embodiment of the present invention.
  • FIG. It is a block diagram for explaining the function of the medical fluid administration device concerning the example of one embodiment of the present invention. It is a flow chart for explaining the procedure of the medical fluid administration method concerning one embodiment example of the present invention.
  • the drug solution administration support system 1 includes a drug solution administration device (pump body) 100 and a remote controller 200 used in combination with the drug solution administration device 100.
  • the drug solution administration device 100 is a drug solution pump that is used by being worn on the skin of a patient in order to administer a drug solution such as insulin to the patient over a long period of time.
  • a drug solution administration device 100 includes a communication unit with the remote controller 200 as described later.
  • the remote controller 200 which operates the drug solution administration device 100, is a mobile terminal such as a smartphone that is carried by the patient and is not worn on the skin of the patient.
  • the remote controller 200 has an integrated operation unit 200 a and display unit 200 b, and also includes a control unit (not shown) and a communication unit with the drug solution administration device 100.
  • the operation unit 200a may be, for example, a display screen of the display unit 200b provided with a touch panel, or may be an operation button provided at a position apart from the display unit 200b.
  • the drug solution administration support system 1 creates a dosing profile in basal insulin administration (basal administration) and doses (bolus amounts) at the time of additional administration (bolus administration) in the drug administration performed by the drug administration device 100. Set the parameters for calculation.
  • the drug solution administration support system 1 is usually composed of a remote controller 200, but a terminal device 300 such as a personal computer or a tablet terminal, which is different from the remote controller 200 and can communicate with the remote controller 200 or the drug solution administration device 100. You may comprise by. In this case, as shown in FIG. 1, the operation unit 300a and the display unit 300b are not integrated.
  • the drug solution administration device 100 used in the present invention includes an insulin pump that continuously or intermittently administers the drug solution filled in the cylindrical body 18 into the living body by the pressing action of the plunger 20.
  • the drug solution administration device 100 includes a disposable disposable unit 12, a reusable reuse unit 14, and a drive unit 40 (see FIG. 3) mainly provided in the reuse unit 14.
  • the disposable part 12 includes a flat box-shaped base part 16 which is open on one side.
  • the base portion 16 is formed so as to be detachable from a cradle (not shown).
  • the cradle includes a cannula placed in the living body and can be attached to the skin of the user (patient).
  • the base portion 16 includes a cylindrical body 18 filled with a chemical solution, a plunger 20 provided in the cylindrical body 18, and a feed screw shaft 22 arranged coaxially with the plunger 20. And a nut portion (movable portion) 24 screwed to the feed screw shaft 22.
  • the tubular body 18 extends in a cylindrical shape along the longitudinal direction of the base portion 16. The outer diameter and the inner diameter of the tip of the tubular body 18 are reduced toward the tip.
  • An introduction port 26 (see FIG. 2) for introducing the chemical liquid into the cylinder body 18 and a discharge port 28 for discharging the chemical liquid in the cylinder body 18 are provided at the tip of the cylinder body 18.
  • a lead-out pipe 29 for guiding the drug solution in the tubular body 18 to a cannula (not shown) communicates with the lead-out port 28.
  • the plunger 20 is configured to be slidable in the tubular body 18 along the axial direction of the tubular body 18. That is, the plunger 20 has the plunger main body 30 that constitutes the front end side and the pusher 32 that pushes the rear end side of the plunger main body 30. A pair of packings 34 is attached to the rear end side of the plunger body 30 which is formed in a cylindrical shape.
  • the pusher 32 includes a pair of extending portions 36 extending rearward from the plunger body 30 to the outside of the cylindrical body 18, and a pair of claw portions 38 provided at the rear end of the extending portion 36.
  • One end of the feed screw shaft 22 is rotatably supported by a bearing 39 and moves the nut portion 24.
  • the drive unit 40 is rotatable integrally with the battery 42 as a power source, a motor 44 driven by the battery 42, a gear box 46 for decelerating and transmitting the rotational driving force of the motor 44, and the feed screw shaft 22. It has a transmission shaft 52 that is locked. A spur gear 50 that meshes with the output gear 48 of the gear box 46 is fixed to the transmission shaft 52.
  • the battery 42 and the transmission shaft 52 shown by the solid line are provided in the disposable section 12, and the motor 44 and the gear box 46 shown by the two-dot chain line are provided in the reuse section 14 (see FIG. 2).
  • the battery 42 is provided with a terminal 54 that electrically connects the battery 42 to the motor 44 when the reuse unit 14 is attached to the disposable unit 12.
  • the transmission shaft 52 is rotatably supported by a pair of bearings 56 provided on the base portion 16 while being coaxially arranged with the feed screw shaft 22.
  • the motor 44 is configured to drive the feed screw shaft 22 to rotate only in the direction in which the nut portion 24 moves to the tip end side of the plunger 20.
  • the nut part 24 has a nut part body 58 formed in a substantially rectangular parallelepiped shape, and a slide part 60 provided on the nut part body 58.
  • the nut body 58 is provided with a screw hole 62 into which the feed screw shaft 22 is screwed, and a pair of through holes 64 formed so as to sandwich the screw hole 62 from both sides and through which the claw portion 38 is inserted.
  • a reinforcement cover 66 made of, for example, a metal material is attached to the outer surface of the nut portion main body 58.
  • the slide part 60 slides along a guide wall 68 extending along the axial direction of the plunger 20.
  • the nut portion 24 is in the initial position where it does not come into contact with the plunger 20, and is moved from the initial position by the rotation action of the feed screw shaft 22, and comes into contact with the plunger 20 to move the plunger 20. Press on the tip side.
  • the reuse unit 14 includes a lid body 70 that closes the opening of the base portion 16, and a control unit 72 provided on the lid body 70.
  • the control unit 72 includes a sensor (initial position detection sensor) 74 that detects the initial position of the nut unit 24, a sensor (predetermined position detection sensor) 76 that detects that the nut unit 24 has reached a predetermined position, and an alert unit. 78 and the drive unit 40 shown in FIG.
  • the predetermined position detection sensor 76 detects the remaining amount of the chemical liquid in the cylindrical body 18. Then, the predetermined position detection sensor 76 functions as a remaining amount switch that operates the alert unit 78 when the amount of the chemical liquid in the cylindrical body 18 becomes a predetermined amount or less (for example, 50 U or less). That is, the predetermined position detection sensor 76 is a contact sensor that comes into contact with the nut portion 24 when the nut portion 24 moves to a predetermined position where the chemical liquid in the tubular body 18 reaches a predetermined amount.
  • the initial position detection sensor 74 detects whether or not the nut portion 24 is in the initial position before moving the nut portion 24.
  • the initial position detection sensor 74 is a contact sensor with which the nut part 24 at the initial position comes into contact when the reuse part 14 is attached to the disposable part 12.
  • the initial position detection sensor 74 can easily detect whether or not the nut portion 24 is at the initial position.
  • the contact sensor is merely an example, and the initial position detection sensor 74 and the predetermined position detection sensor 76 can be configured as non-contact sensors.
  • the predetermined position detection sensor 76 As described above, by configuring the predetermined position detection sensor 76 as a contact or non-contact sensor, it is possible to easily detect whether or not the nut portion 24 has reached a predetermined position (a position for issuing a chemical solution remaining amount alert). .. Further, although the initial position detection sensor 74 and the predetermined position detection sensor 76 are provided in the reuse unit 14, both or one of the initial position detection sensor 74 and the predetermined position detection sensor 76 is provided on the disposable unit 12 side. Good.
  • the alert unit 78 as a notification unit may output only one type of alert sound, but it may also output multiple types of alert sounds. In that case, at least one of the frequency, the amplitude, the output time, and the output frequency of the sound may be made different. It should be noted that the alert unit 78 is not always necessary, and the remaining amount of the liquid medicine is low on the display units 200b and 300b of the remote controller 200 or the terminal device 300 shown in FIG. You may also display that it has become.
  • the drug solution administration device 100 used in the present invention is configured as described above, and its operation and action will be described below.
  • the drug solution is not filled in the cylindrical body 18 of the disposable part 12.
  • the nut portion 24 is in the initial position where it does not contact the plunger 20.
  • the user adjusts the position of the plunger 20 with respect to the cylinder 18 and fills the cylinder 18 with an appropriate amount of the drug solution from the drug solution container in which the drug solution is hermetically stored.
  • the reuse section 14 is attached to the disposable section 12.
  • the output gear 48 of the gear box 46 of the reuse section 14 meshes with the spur gear 50 of the disposal section 12, and the battery 42 of the disposal section 12 supplies electric power to the components of the reuse section 14.
  • the control unit 72 is activated by the electric power of the battery 42, and the initial position detection sensor 74 detects that the nut unit 24 is at the initial position. It is assumed that the disposable part 12 is not used but is unused.
  • the remote controller 200 shown in FIG. 1 is operated to rotationally drive the motor 44 of the drug solution administration device 100. Then, the rotational driving force of the motor 44 is transmitted to the feed screw shaft 22 via the gear box 46, the spur gear 50, and the transmission shaft 52. Then, the feed screw shaft 22 rotates, and the nut portion 24 advances toward the plunger 20 side while sliding on the guide wall 68.
  • the pair of claw portions 38 are inserted into the through holes 64 of the nut portion 24, and the pair of extending portions 36 bend so as to be close to each other.
  • the pawl portion 38 passes through the through hole 64, the pawl portion 38 returns to its original position and the nut portion 24 is locked to the plunger 20.
  • the nut portion 24 can press the tip side of the plunger 20. Then, by further advancing the nut portion 24, the chemical liquid in the cylindrical body 18 is pressed by the plunger 20 and the inner hole of the outlet pipe 29 is filled with the chemical liquid, and the priming is completed.
  • the user attaches a cradle (not shown) to a predetermined position on the skin, and uses the puncture mechanism to leave the cannula locked in the cradle in the living body.
  • the drug solution administration device 100 is connected to the cradle, the lead-out tube 29 and the cannula communicate with each other, and the motor control unit (not shown) in the control unit 72 controls the rotation of the motor 44 so that the drug solution in the tubular body 18 is maintained in the living body. Administered intermittently or intermittently.
  • the predetermined position detection sensor 76 detects that the nut portion 24 moved from the initial position has arrived at a predetermined position (a position for issuing an alert of the remaining amount of the chemical liquid in the tubular body 18). That is, when the nut portion 24 reaches the predetermined position, the predetermined position detection sensor 76 is turned on and the alert sound is output from the alert portion 78. Alternatively, the remaining amount alert is displayed on the display screen of the display unit 200b of the remote controller 200. Here, as shown in FIG. 4, a display such as "The remaining amount of the remaining amount of the reservoir is 50U" is displayed. As a result, the user can know that the remaining amount of the chemical liquid in the cylindrical body 18 has reached a predetermined amount (for example, 50 U). Then, in the case of intermittently administering the liquid medicine in an amount larger than the predetermined amount, it is possible to take measures such as exchanging the disposable part 12 with an unused product.
  • a predetermined position a position for issuing an alert of the remaining amount of the chemical liquid in the tub
  • the remaining amount switch (a predetermined position in FIG. 2) of a value (for example, 50 U) that usually alerts the remaining amount of the liquid medicine from the total daily dose of the set basal rate pattern is set. It is determined whether or not the detection sensor 76) is used. When it is determined that the 50U remaining amount switch is not used, that is, when the value for issuing the remaining amount alert is 50U or less, the remaining amount X of the chemical liquid of 50U or less is set by software, and the remaining amount of the chemical liquid is set. The remaining amount alert is notified when the amount reaches X.
  • the point that the remaining amount of the remaining amount alert is set to 50 U is merely an example, and the remaining amount value of this alert is set to a predetermined value (hereinafter, “predetermined value”) according to the profile of the patient. It
  • FIG. 5A shows, as an example, three patterns 1 to 3 in setting the basal rate administration stored in the controller 200.
  • Pattern 1 is a pattern for selecting a normal weekday basal rate administration.
  • Pattern 2 is a basal rate administration pattern when the patient is exercising, and in this case, the dose is smaller than in normal times.
  • Pattern 3 is a basal rate administration pattern when the user is ill, and in this case, the dose varies depending on the individual user.
  • the user's profile is selected from preset basal rate administration patterns 1 to 3.
  • the basal rate dosing pattern is selected according to.
  • the basal rate administration pattern is not limited to the three patterns shown in FIG. 5A.
  • the setting can be changed depending on the weight difference of the user who is the user.
  • the basal rate administration pattern is changed by touching any of the display screens (FIG. 5A) of the remote controller 200.
  • the full amount of the drug solution for three days filled in the cylindrical body 18 is about 200 U, and when the remaining amount becomes 50 U which is a quarter, It is set to issue a remaining amount alert.
  • This value is a value that changes depending on the weight of an adult.
  • the total amount of drug solution to be administered in 3 days is usually set to about 60 U, though it depends on the weight.
  • the total daily dose at the basal rate is 10.20 U
  • the frequency of replacement of the disposable part 12 is once every three days, and the margin including the bolus amount is doubled
  • the total daily dose will be three days.
  • 61.2 [U]/4 15.3 [U]
  • a remaining amount alert may be issued. That is, it is necessary to set a value smaller than the usual adult setting value of 50 U as the remaining amount alert value.
  • FIG. 6 is a block diagram showing the functions of the drug solution administration device (pump body) 100 and the remote controller 200 according to the embodiment of the present invention.
  • the drug solution administration device 100 includes a power supply unit 101, a drive unit 102, a remaining amount detection unit 103, an output unit 104, a date/time management unit 105, a data storage unit 106, a main body communication unit 107, and a main body calculation unit 108 that controls these. ..
  • the power supply unit 101 is for supplying electric power to each constituent element of the chemical liquid administration device 100, and includes, for example, the battery 42 shown in FIGS. 2 and 3, a battery box (not shown) that houses the battery 42, and a battery. It is composed of a switch (not shown) for turning on/off the power supply from 42.
  • the drive unit 102 is for performing drug solution administration to a patient wearing the drug solution administration device 100, and corresponds to the drive unit 40 in FIG. 3. That is, as described with reference to FIGS. 2 and 3, the drive unit 102 includes the cylinder 18 for containing the liquid medicine to be administered, the pusher 32 slid in the cylinder 18, and the motor for moving the pusher 32. 44 and a gear box 46 and the like.
  • the remaining amount detection unit 103 includes a remaining amount switch (predetermined position detection sensor 76 in FIGS. 2 and 3) and a counter unit (not shown).
  • the counter unit counts the number of rotations of the motor 44.
  • the remaining amount detection unit 103 outputs a detection signal to the main body calculation unit 108 when the predetermined position detection sensor 76 detects the remaining amount of a predetermined amount (for example, 50 U) of the chemical liquid to be alerted. Then, the main body calculation unit 108 activates the alert unit 78 to generate an alarm sound.
  • a signal for sending an alert is sent to the remote controller 200 via the main body communication unit 107, and, for example, on the display screen of the display unit 200b of the remote controller 200, for example, as shown in FIG. Is displayed.”
  • the remaining amount detection unit 103 outputs the rotation speed of the motor 44 counted by the counter unit to the main body calculation unit 108.
  • the main body calculation unit 108 counts the remaining amount of the chemical liquid based on the rotation speed of the motor 44 output from the remaining amount detection unit 103.
  • this alert is issued only when the amount of drug solution, which is a quarter of the total dose for 3 days, is 50 U or more.
  • the amount of the drug solution that is a quarter of the total dose for 3 days is less than 50 U, even if the position of the predetermined position detection sensor 76 is detected, an alert is not issued and a counter unit (not shown)
  • the remaining amount of the chemical liquid in the cylindrical body 18 is counted.
  • the remaining amount of the chemical liquid is counted by counting the number of rotations of the motor 44 with an encoder (not shown).
  • the main body calculation unit 108 of the liquid medicine administration device 100 transfers the remote controller 200 to the remote controller 200 via the main body communication unit 107. Send a signal to display an alert.
  • the controller operation unit 208 of the remote controller 200 alerts the display screen of the display unit 204, for example, "remaining low amount of the reservoir X is X". Display.
  • the output unit 104 as a notification unit is, for example, the alert unit 78 shown in FIG. 2, and normally, when communication between the chemical solution administration device 100 and the remote controller 200 is interrupted, an alarm is issued by an instruction from the main body calculation unit 108. Output.
  • the alarm vibration or sound may be used alone or in combination, or may emit light.
  • the date and time management unit 105 is a program function for performing date and time management, and is a function installed in a general microcomputer to output date and time information. Since the date and time management unit 105 is supplied with power even when the power is off, it is possible to output accurate date and time information.
  • the data storage unit 106 stores various data for controlling the drug solution administration device 100.
  • the remote controller 200 issues an alert calculated based on the basal rate administration pattern of the patient.
  • the alert value X of the remaining amount of the chemical liquid is included.
  • controller forget prevention function data for example, controller forget prevention function data, automatic bolus administration data, administration history data, basic rate administration data (basal administration data), data for pairing, and the like. Note that these data have no direct relationship with the present embodiment and are described in detail in Japanese Unexamined Patent Application Publication No. 2017-148393, which is a prior patent document, and therefore description thereof will be omitted.
  • the main body communication unit 107 performs wireless communication between the drug solution administration device 100 and the remote controller 200.
  • the main body communication unit 107 has a transmission unit and a reception unit, and performs radio communication using radio waves in a predetermined wavelength band, for example, ultrashort waves or microwaves.
  • the main body communication unit 107 transmits/receives a signal to/from the controller communication unit 207 in the paired remote controller 200 according to an instruction from the main body calculation unit 108 to establish communication with the controller communication unit 207. To do.
  • the main body calculation unit 108 stores various data received by the main body communication unit 107 in the data storage unit 106. Further, the main body arithmetic unit 108 drives the drive unit 102 based on the signal transmitted from the remote controller 200, and outputs an alarm from the output unit 104. Furthermore, the main body calculation unit 108 drives the drive unit 102 based on various data stored in the data storage unit 106, and performs basal insulin administration and bolus of insulin to the user (patient) who wears the drug solution administration device 100. Control dosing.
  • the remote controller 200 includes a power supply unit 201, an input unit 202, an output unit 203, a display unit 204, a date/time management unit 205, a data storage unit 206, a controller communication unit 207, and a controller operation for controlling them.
  • the unit 208 is provided.
  • constituent elements those having the same function as the constituent elements of the drug solution administration device 100 will be omitted, and only the constituent elements having a different function from the drug solution administration device 100 will be described.
  • the display unit 204 in addition to displaying an alert when the remaining amount of the liquid medicine is below a predetermined value, displays various setting contents, contents input by the input unit 202, or the liquid medicine administration device 100.
  • the administration history, etc. are displayed.
  • the display unit 204 is composed of, for example, a liquid crystal display. 4 and 5 are examples of display screens displayed on the display unit 204. In addition to this screen, the display unit 204 also displays various data used for the operation of the drug solution administration device 100. It
  • the input unit 202 inputs data such as an on/off operation of a power source, settings of insulin administration by the drug solution administration device 100, and display contents on the display unit 204.
  • the input unit 202 includes, for example, a keypad and a touch panel provided on the front surface of the display unit 204.
  • the functions of the output unit 203, the date/time management unit 205, the data storage unit 206, and the controller communication unit 207 are the same as those of the output unit 104, the date/time management unit 105, the data storage unit 106, and the main body communication unit 107 of the drug administration device 100. Then, the description is omitted.
  • the controller calculation unit 208 stores the various settings input in the input unit 202 and the remaining amount alert value X of the chemical liquid that issues an alert in the data storage unit 206. Then, the data necessary for the drug solution administration device 100 side, including the alert value X of the remaining amount of the drug solution that issues an alert, is transmitted to the main body communication unit 107 of the drug solution administration device 100 via the controller communication unit 207.
  • FIG. 7 is a flowchart for explaining the procedure of the drug solution administration method according to the embodiment of the present invention.
  • a basal rate administration pattern of the drug solution is selected (step S1).
  • the optimal basal rate administration pattern is selected according to the patient's condition (profile) from the plurality of basal rate administration patterns displayed on the display unit 204 of the remote controller 200 as shown in FIG. 5A. To be done. This selection is made by the input unit 202.
  • the controller calculation unit 208 calculates the remaining amount alert value X when issuing the remaining amount alert according to the condition (profile) of the patient (step S2). As described above, the remaining amount alert value X for issuing this alert differs depending on whether the patient is an adult or a child. Further, since the timing of medication varies depending on whether it is during normal times, during exercise, or during illness, it is necessary to calculate the optimum remaining amount alert value X that issues an alert during basal rate administration. It should be noted that the calculation of the remaining amount alert value X when issuing this alert may be performed by the main body calculation unit 108 of the drug solution administration device 100.
  • the position of the remaining amount switch (predetermined position detection sensor 76 in FIG. 2) is set to a fixed value, for example, 50 U regardless of whether or not a remaining amount alert is generated. Set to the position.
  • step S3 determines whether or not the calculated remaining amount alert value X is less than 50 U (step S3).
  • step S3 when the main body calculation unit 108 determines that the remaining amount alert value X is 50 U or more (NO in step S3), the liquid medicine administration is started (step S4), and the remaining amount of the liquid medicine is the predetermined value 50U.
  • step S5 the remaining amount switch for issuing the remaining amount alert is used (step S5). Note that step S4 and step S5 do not have to be in this order. It does not matter if the "use of the remaining amount switch" in step S5 is brought before the "start of drug solution administration" in step S4.
  • step S6 determines whether or not the remaining amount switch is pressed. If the remaining amount switch is not pressed in step S6 (NO in step S6), the process waits until it is pressed. When the remaining amount switch is pressed in step S6 (YES in step S6), the remaining amount detection unit 103 outputs a detection signal to the main body calculation unit 108. Then, the main body calculation unit 108 outputs the remaining amount alert signal to the output unit 104 and the remote controller 200.
  • the output unit 104, the output unit 203 of the remote controller 200, and the display unit 204 notify the patient as a remaining amount alert that the remaining amount value of the drug solution in the cylindrical body 18 has reached the predetermined value 50U (step S7). ), the processing ends.
  • step S3 when it is determined in step S3 that the calculated remaining amount alert value X is less than the predetermined value 50U (YES in step S3), the main body calculation unit 108 leaves the value for issuing the remaining amount alert.
  • the amount alert value X is set (step S8), and administration of the liquid medicine is started (step S9).
  • step S10 determines whether or not the remaining amount switch is pressed by the slide unit 60 (step S10). The determination in step S10 is not always necessary when the remaining amount alert value X for issuing an alert is less than 50U. Here, even if the remaining amount switch is pressed, the remaining amount alert is not generated.
  • the remaining amount switch is merely used as a predetermined position detection switch, the position of the remaining amount switch is always guided by the sliding portion 60 of FIG. 3 regardless of whether or not a remaining amount alert is issued.
  • the wall 68 is set at a predetermined position (position where the remaining amount of the chemical liquid is 50 U). Therefore, if the remaining amount alert value X for generating an alert is less than 50 U, the remaining amount alert signal is not output even if the remaining amount switch is pressed.
  • step S10 the main body calculation unit 108 starts counting the remaining amount of the chemical liquid in the tubular body 18 after the remaining amount switch is pressed (step S10). S11). This counting is performed, for example, by the counter unit of the remaining amount detecting unit 103 based on the number of rotations of the motor 44. Alternatively, the amount of movement of the plunger 20 may be calculated from the number of rotations of the motor 44 counted by the counter unit of the remaining amount detecting unit 103, and the remaining amount of the chemical liquid may be counted.
  • the present invention is not limited to this, and the number of rotations of the feed screw shaft 22 may be counted as the counter unit, or the movement of the plunger 20 may be performed. The amount may be counted directly.
  • the main body calculation unit 108 determines whether or not the remaining amount count value in step S11 is equal to the remaining amount alert value X for issuing an alert (step S12).
  • the remaining amount count value is the amount of chemical liquid calculated from the remaining amount (50 U) at the position of the remaining amount switch based on the rotation speed of the motor 44 counted by the counter unit of the remaining amount detecting unit 103, that is, The value is the value obtained by subtracting the amount of the chemical solution sent after pressing the remaining amount switch.
  • the process of step S12 is repeated until the remaining amount count value reaches the remaining amount alert value X for issuing an alert (NO in step S12).
  • step S12 when the remaining amount count value reaches the remaining amount alert value X for issuing an alert (YES in step S12), the main body calculation unit 108 of the drug administration device 100 outputs the remaining amount alert signal to the output unit 104. Or output to the remote controller 200. Accordingly, the alert sound is generated by the alert unit 78, or the remaining amount alert is displayed on the display unit 204 of the remote controller 200 via the main body communication unit 107, and the remaining amount alert is notified to the patient. (Step S7).
  • the remaining amount switch is pressed after the start of the chemical liquid administration in step S9, and then the remaining amount counting in step S11 is started.
  • the remaining amount alert value X for issuing the remaining amount alert is less than the predetermined value 50U
  • the remaining amount count in step S11 can be started at the timing of starting the liquid medicine administration in step S9.
  • the chemical solution administration device and the chemical solution administration method of the present invention are not limited to the embodiment described herein, and are within the scope of the present invention described in the claims.
  • Various changes are possible.
  • the chemical solution administration device 100 and the remote controller 200 are shown as connected to each other via a network, but the configuration of the controller 200 is incorporated into the chemical solution administration device 200 to form an integrated chemical solution administration device.
  • an insulin pump that administers insulin is applied as the drug solution administration device
  • the invention is not limited to this.
  • various other drug solutions such as analgesics, anti-cancer therapeutic agents, HIV drugs, iron chelating agents, pulmonary hypertension therapeutic agents and the like may be used.
  • Chemical liquid administration support system 100... Chemical liquid administration device (pump main body), 200... Remote controller, 300... Terminal device, 12... Disposable part, 14... Reuse part, 16... Base part, 18... Cylindrical body, 20... Plunger , 26... Introduction port, 28... Outflow port, 24... Nut part, 40... Drive part, 42... Battery, 52... Transmission shaft, 60... Slide part, 22... Feed screw shaft, 70... Lid body, 72... Control part , 78... Alert unit, 76... Predetermined position detection sensor (remaining amount switch), 74... Initial position detection sensor, 101, 201... Power supply unit, 102... Driving unit, 103... Remaining amount detection unit, 104, 203...
  • Output unit 105, 205... Date/time management section, 106, 206... Data storage section, 107... Main body communication section, 108... Main body calculation section, 202... Input section, 204... Display section, 207... Controller communication section, 208... Controller calculation section

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

To be able to change the residual amount of a liquid medicine at which an alert is generated according to a patient's profile from the total dosage per day of a set basal rate pattern, the total dosage of the liquid medicine is calculated and a residual amount value at which a residual amount alert is generated according to the patient's condition is calculated on the basis of the basal rate delivery pattern of the patient to whom the liquid medicine is administered. When the calculated residual amount value is equal to or above a predetermined value that is set in advance for pressing a residual amount switch, the residual amount alert is generated when a residual amount switch is pressed, and when the calculated residual amount value is less than the set predetermined value, the residual amount alert is generated when the residual amount of the liquid medicine is counted and the count value reaches the residual value.

Description

薬液投与装置及び薬液投与方法Chemical liquid administration device and chemical liquid administration method
 本発明は、薬液投与装置及び薬液投与方法に関し、特に、患者のプロファイルに依存して薬液の投与方法を変更することが可能な薬液投与装置及び薬液投与方法に関する。 The present invention relates to a drug administration device and a drug administration method, and more particularly to a drug administration device and a drug administration method capable of changing the drug administration method depending on the profile of a patient.
 近年、皮下注射や静脈内注射などによって、患者の体内に薬液を持続的に投与する治療法が行われている。例えば、糖尿病患者に対する治療法として、患者の体内に微量のインスリンを持続的に注入する治療が実施されている。この治療法では、一日中患者に薬液(インスリン)を投与するために、患者の身体または衣服に固定する持ち運び可能な携帯型の薬液投与装置(いわゆるインスリンポンプ)が用いられている。 In recent years, treatment methods that continuously administer the drug solution into the patient's body by subcutaneous injection or intravenous injection have been performed. For example, as a treatment method for diabetic patients, a treatment of continuously injecting a small amount of insulin into the body of the patient has been carried out. In this treatment method, a portable liquid medicine administration device (so-called insulin pump) fixed to the patient's body or clothes is used to administer the medicine liquid (insulin) to the patient all day long.
 そして、このような薬液投与装置において、薬液を貯蔵する筒体内にどれだけの薬液が残っているかを使用者に通知することは、極めて重要なことであった。
 しかし、従来の薬液投与装置では、筒体内の薬液の残量が所定量、例えば、3日分の満量が200U(ユニット)であれば、その4分の1の50U(ユニット)になったときに、残量アラートを通知するだけであった。
In such a drug solution administration device, it is extremely important to notify the user of how much drug solution remains in the cylinder that stores the drug solution.
However, in the conventional drug solution administration device, if the remaining amount of the drug solution in the cylinder is a predetermined amount, for example, the full amount for 3 days is 200 U (unit), it becomes 1/4 that of 50 U (unit). At times, I only notified the remaining amount alert.
 特許文献1には、筒体内に充填した薬液をプランジャの押圧作用下により生体内に持続的または間欠的に投与する携帯型の薬液投与装置であって、プランジャの押圧作用によって移動するスライドナットの位置によって、筒体内の薬液の残量が所定量になったことをユーザに通知する接触センサが示されている。
国際公開2016/132937号公報
Patent Document 1 discloses a portable drug solution administration device that continuously or intermittently administers a drug solution filled in a cylinder into a living body under the pressing action of a plunger. Depending on the position, the contact sensor that notifies the user that the remaining amount of the drug solution in the cylinder has reached a predetermined amount is shown.
International publication 2016/132937
 しかしながら、体内に投与する薬液の量には個人差があり、例えば大人と子供(特に小児)では、1日の投与する薬液の量が大きく異なるのが通常である。また、平日、運動時あるいは病気時、食事内容など、患者の状態によっても、投与する薬液の量が変わってくる。したがって、アラートを患者に通知する時点の筒体内の薬液の残量を所定量(例えば、50U)に決めることは適切ではなかった。例えば、小児では、3日間で50U前後のインスリンを充填して使用することがあり、この場合には残量50Uのアラートは余りにも早すぎることになる。 However, there are individual differences in the amount of drug solution that is administered to the body, and for example, the amount of drug solution that is administered daily for adults and children (particularly children) is usually very different. In addition, the amount of drug solution to be administered also changes depending on the patient's condition such as weekdays, exercising or illness, and meal content. Therefore, it was not appropriate to determine the predetermined amount (for example, 50 U) of the residual amount of the liquid medicine in the cylinder at the time of notifying the patient of the alert. For example, a child may use about 50 U of insulin filled in 3 days, and in this case, the alert of the remaining amount of 50 U is too early.
 本発明は、上記課題を解決するためになされたものであり、薬液の総投与量から、アラートを発生する薬液の残量を、所定量(例えば、50U)に固定しないで、患者の状況(プロファイル)に応じて変えることができる薬液投与装置及び薬液投与方法を提供することを目的とする。 The present invention has been made in order to solve the above-described problems, and does not fix the remaining amount of the drug solution that generates an alert to a predetermined amount (for example, 50 U) from the total dose of the drug solution, and the patient situation ( It is an object of the present invention to provide a liquid medicine administration device and a liquid medicine administration method that can be changed according to the profile).
 上記課題を解決し、本発明の目的を達成するため、本発明は、筒体内の薬液の残量が所定値になったときに残量アラートを発する薬液投与装置であって、薬液の総投与量を計算するとともに、薬液の総投与量から残量アラートを発する残量値を計算し、残量アラート信号を出力する演算部と、演算部が出力した残量アラート信号に基づいて残量アラートを発する報知部と、を備える。
 そして、演算部は、計算した残量値が所定値以上のときは、薬液の残量が所定値になったときに残量アラート信号を報知部に出力し、計算した残量値が所定値未満のときは、薬液の残量をカウントし、そのカウント値が計算した残量値に達したときに、残量アラート信号を報知部に出力する。
In order to solve the above problems and achieve the object of the present invention, the present invention is a drug solution administration device which issues a residual amount alert when the residual amount of the drug solution in the cylinder reaches a predetermined value, and the total administration of the drug solution. In addition to calculating the amount, the remaining amount value that issues a remaining amount alert from the total dose of the drug solution and outputs the remaining amount alert signal, and the remaining amount alert signal based on the remaining amount alert signal output from the calculating unit And a notification unit that emits.
Then, when the calculated remaining amount value is equal to or larger than the predetermined value, the calculation unit outputs a remaining amount alert signal to the notification unit when the remaining amount of the chemical liquid reaches the predetermined value, and the calculated remaining amount value is the predetermined value. When it is less than, the remaining amount of the chemical liquid is counted, and when the count value reaches the calculated remaining amount value, the remaining amount alert signal is output to the notification unit.
 また、本発明の薬液投与方法は、筒体内の薬液の残量が所定値になったときに残量アラートを発する薬液投与方法であって、以下のステップを含む。
(a)薬液の総投与量から残量アラートを発する薬液の残量値を演算部により計算するステップ、
(b)残量アラートを発する残量値が所定値以上のときは、薬液の残量が所定値になったときに残量アラート信号を演算部により出力するステップ、
(c)残量アラートを発する残量値が所定値未満のときは、薬液の残量が所定値になったときに薬液の残量のカウントを演算部により開始するステップ、
(d)前記カウントの値が残量アラートを発する残量値になったときに、残量アラート信号を演算部により出力するステップ。
Further, the drug solution administration method of the present invention is a drug solution administration method that issues a residual amount alert when the residual amount of the drug solution in the cylinder reaches a predetermined value, and includes the following steps.
(A) A step of calculating the remaining amount value of the liquid medicine which issues a remaining amount alert from the total dose of the liquid medicine by a calculation unit,
(B) When the remaining amount value for issuing the remaining amount alert is equal to or greater than a predetermined value, a step of outputting a remaining amount alert signal by the calculation unit when the remaining amount of the chemical liquid reaches the predetermined value,
(C) When the remaining amount value for issuing the remaining amount alert is less than a predetermined value, a step of starting the counting of the remaining amount of the medical liquid by the calculation unit when the remaining amount of the medical liquid reaches the predetermined value,
(D) A step of outputting a remaining amount alert signal by a computing unit when the count value reaches a remaining amount value for issuing a remaining amount alert.
 本発明によれば、大人と子供、あるいは患者の状態を考慮して、筒体内の薬液の残量のアラートを患者の最適な状況下で通知することができる。 According to the present invention, it is possible to notify the alert of the remaining amount of the liquid medicine in the cylinder under the optimal condition of the patient in consideration of the condition of the adult, the child, or the patient.
本発明の一実施形態例に係る薬液投与装置が用いられる薬液投与支援システムの一例を示す構成図である。It is a block diagram which shows an example of the chemical|medical solution administration support system in which the chemical|medical solution administration apparatus which concerns on the example of one Embodiment of this invention is used. 本発明の一実施形態例に係る薬液投与装置の分解斜視図である。FIG. 1 is an exploded perspective view of a drug solution administration device according to an embodiment of the present invention. 本発明の一実施形態例に係る薬液投与装置の断面図である。It is a sectional view of a medical fluid administration device concerning one example of an embodiment of the present invention. 本発明の一実施形態例に係る薬液投与装置における薬液の残量低下を示す表示画面である。6 is a display screen showing a decrease in the amount of remaining liquid medicine in the liquid medicine administration device according to the embodiment of the present invention. 本発明の一実施形態例に係る薬液投与装置における、予め設定した投与パターンを変更するときの表示画面Aと、基礎レートパターンを確認して決定するときの表示画面Bである。FIG. 7 is a display screen A when changing a preset administration pattern and a display screen B when confirming and determining a basal rate pattern in the drug solution administration device according to the embodiment of the present invention. FIG. 本発明の一実施形態例に係る薬液投与装置の機能を説明するためのブロック図である。It is a block diagram for explaining the function of the medical fluid administration device concerning the example of one embodiment of the present invention. 本発明の一実施形態例に係る薬液投与方法の手順を説明するためのフローチャートである。It is a flow chart for explaining the procedure of the medical fluid administration method concerning one embodiment example of the present invention.
<薬液投与支援システムの全体構成の説明>
 まず、本発明の一実施形態例を説明する前に、本発明の一実施形態例に係る薬液投与装置が用いられる薬液投与支援システムの概要を図1に基づいて説明する。
 図1に示すように、薬液投与支援システム1は、薬液投与装置(ポンプ本体)100と、この薬液投与装置100と組み合わせて用いられるリモートコントローラ200により構成されている。
<Description of the overall configuration of the drug solution administration support system>
First, before explaining an embodiment of the present invention, an outline of a drug administration support system in which a drug administration device according to an embodiment of the present invention is used will be described with reference to FIG.
As shown in FIG. 1, the drug solution administration support system 1 includes a drug solution administration device (pump body) 100 and a remote controller 200 used in combination with the drug solution administration device 100.
 薬液投与装置100は、長時間にわたって患者にインスリンなどの薬液を投与するために、患者の皮膚に装着して用いられる薬液ポンプである。このような薬液投与装置100は、後述するようにリモートコントローラ200との通信部を備えている。 The drug solution administration device 100 is a drug solution pump that is used by being worn on the skin of a patient in order to administer a drug solution such as insulin to the patient over a long period of time. Such a drug solution administration device 100 includes a communication unit with the remote controller 200 as described later.
 一方、リモートコントローラ200は、薬液投与装置100を操作するものであるが、患者の皮膚に装着されない状態で、患者が携帯して用いるスマートフォンのような携帯端末である。
 リモートコントローラ200は、一体化された操作部200a及び表示部200bを有し、また不図示の制御部、及び薬液投与装置100との通信部を備える。操作部200aは、例えばタッチパネルを設けた表示部200bの表示画面でもよいが、表示部200bから離れた位置に設けた操作ボタンでもよい。
On the other hand, the remote controller 200, which operates the drug solution administration device 100, is a mobile terminal such as a smartphone that is carried by the patient and is not worn on the skin of the patient.
The remote controller 200 has an integrated operation unit 200 a and display unit 200 b, and also includes a control unit (not shown) and a communication unit with the drug solution administration device 100. The operation unit 200a may be, for example, a display screen of the display unit 200b provided with a touch panel, or may be an operation button provided at a position apart from the display unit 200b.
 薬液投与支援システム1は、薬液投与装置100によって実施される薬液投与において、インスリンの基礎投与(ベーサル投与)における投与プロファイルの作成と、追加投与(ボーラス投与)の際の投与量(ボーラス量)を算出するためのパラメータを設定する。 The drug solution administration support system 1 creates a dosing profile in basal insulin administration (basal administration) and doses (bolus amounts) at the time of additional administration (bolus administration) in the drug administration performed by the drug administration device 100. Set the parameters for calculation.
 この薬液投与支援システム1は、通常リモートコントローラ200によって構成されるが、リモートコントローラ200とは別の、リモートコントローラ200または薬液投与装置100との通信が可能なパーソナルコンピュータやタブレット端末などの端末装置300によって構成してもよい。この場合、図1に示すように、操作部300aと、表示部300bは、一体化されない構成となる。 The drug solution administration support system 1 is usually composed of a remote controller 200, but a terminal device 300 such as a personal computer or a tablet terminal, which is different from the remote controller 200 and can communicate with the remote controller 200 or the drug solution administration device 100. You may comprise by. In this case, as shown in FIG. 1, the operation unit 300a and the display unit 300b are not integrated.
<薬液投与装置の構成の説明>
 次に、本発明の実施形態例に用いられる薬液投与装置100の構成と動作を図2~図4を参照して説明する。本発明に用いられる薬液投与装置100は、筒体18内に充填した薬液をプランジャ20の押圧作用により生体内に持続的または間欠的に投与するインスリンポンプを備える。
<Explanation of the configuration of the drug solution administration device>
Next, the configuration and operation of the chemical liquid administration device 100 used in the embodiment of the present invention will be described with reference to FIGS. 2 to 4. The drug solution administration device 100 used in the present invention includes an insulin pump that continuously or intermittently administers the drug solution filled in the cylindrical body 18 into the living body by the pressing action of the plunger 20.
 図2に示すように、薬液投与装置100は、使い捨てのディスポ部12と、再利用可能なリユース部14と、主にリユース部14に設けられる駆動部40(図3参照)とを有する。ディスポ部12は、片側が開口した平箱形状のベース部16を備える。ベース部16は、不図示のクレードルと着脱可能に形成される。なお、クレードルは、生体内に留置されるカニューレを含み、ユーザ(患者)の皮膚に貼着可能である。 As shown in FIG. 2, the drug solution administration device 100 includes a disposable disposable unit 12, a reusable reuse unit 14, and a drive unit 40 (see FIG. 3) mainly provided in the reuse unit 14. The disposable part 12 includes a flat box-shaped base part 16 which is open on one side. The base portion 16 is formed so as to be detachable from a cradle (not shown). The cradle includes a cannula placed in the living body and can be attached to the skin of the user (patient).
 図2及び図3に示すように、ベース部16は、薬液が充填される筒体18と、筒体18内に設けられたプランジャ20と、プランジャ20と同軸に配設された送りねじ軸22と、送りねじ軸22に螺合されたナット部(可動部)24を備える。  As shown in FIGS. 2 and 3, the base portion 16 includes a cylindrical body 18 filled with a chemical solution, a plunger 20 provided in the cylindrical body 18, and a feed screw shaft 22 arranged coaxially with the plunger 20. And a nut portion (movable portion) 24 screwed to the feed screw shaft 22. 
 筒体18は、ベース部16の長手方向に沿って円筒状に延在する。そして、筒体18の先端部は、外径及び内径が先端に向かって縮径している。筒体18の先端部には、筒体18内へ薬液を導入するための導入ポート26(図2参照)と、筒体18内の薬液を導出するための導出ポート28が設けられている。導出ポート28には、筒体18内の薬液を不図示のカニューレに導く導出管29が連通している。  The tubular body 18 extends in a cylindrical shape along the longitudinal direction of the base portion 16. The outer diameter and the inner diameter of the tip of the tubular body 18 are reduced toward the tip. An introduction port 26 (see FIG. 2) for introducing the chemical liquid into the cylinder body 18 and a discharge port 28 for discharging the chemical liquid in the cylinder body 18 are provided at the tip of the cylinder body 18. A lead-out pipe 29 for guiding the drug solution in the tubular body 18 to a cannula (not shown) communicates with the lead-out port 28. 
 プランジャ20は、筒体18内に、筒体18の軸線方向に沿って摺動可能に構成されている。すなわち、プランジャ20は、先端側を構成するプランジャ本体30と、プランジャ本体30の後端側を押す押し子32を有している。プランジャ本体30のうち円筒状に形成された後端側には、一対のパッキン34が装着されている。  The plunger 20 is configured to be slidable in the tubular body 18 along the axial direction of the tubular body 18. That is, the plunger 20 has the plunger main body 30 that constitutes the front end side and the pusher 32 that pushes the rear end side of the plunger main body 30. A pair of packings 34 is attached to the rear end side of the plunger body 30 which is formed in a cylindrical shape. 
 押し子32は、プランジャ本体30から後方に向かって筒体18の外側まで伸びた一対の延出部36と、延出部36の後端部に設けられた一対の爪部38を備える。送りねじ軸22は、その一端部が軸受39によって軸支されており、ナット部24を移動させる。  The pusher 32 includes a pair of extending portions 36 extending rearward from the plunger body 30 to the outside of the cylindrical body 18, and a pair of claw portions 38 provided at the rear end of the extending portion 36. One end of the feed screw shaft 22 is rotatably supported by a bearing 39 and moves the nut portion 24. 
 駆動部40は、動力源としての電池42と、電池42によって駆動されるモータ44と、モータ44の回転駆動力を減速して伝達するギヤボックス46と、送りねじ軸22と一体で回転可能に係止される伝達軸52を有する。なお、伝達軸52には、ギヤボックス46の出力歯車48に噛み合う平歯車50が固定されている。  The drive unit 40 is rotatable integrally with the battery 42 as a power source, a motor 44 driven by the battery 42, a gear box 46 for decelerating and transmitting the rotational driving force of the motor 44, and the feed screw shaft 22. It has a transmission shaft 52 that is locked. A spur gear 50 that meshes with the output gear 48 of the gear box 46 is fixed to the transmission shaft 52. 
 本実施形態では、実線で示す電池42及び伝達軸52がディスポ部12に設けられ、二点鎖線で示すモータ44及びギヤボックス46がリユース部14(図2参照)に設けられている。電池42には、ディスポ部12にリユース部14を装着する際に、電池42をモータ44に電気的に接続する端子54が設けられている。伝達軸52は、送りねじ軸22と同軸に配設された状態でベース部16に設けられた一対の軸受56によって軸支されている。 なお、モータ44は、ナット部24がプランジャ20の先端側に移動する方向にのみ送りねじ軸22を回転駆動させるように構成されている。  In this embodiment, the battery 42 and the transmission shaft 52 shown by the solid line are provided in the disposable section 12, and the motor 44 and the gear box 46 shown by the two-dot chain line are provided in the reuse section 14 (see FIG. 2). The battery 42 is provided with a terminal 54 that electrically connects the battery 42 to the motor 44 when the reuse unit 14 is attached to the disposable unit 12. The transmission shaft 52 is rotatably supported by a pair of bearings 56 provided on the base portion 16 while being coaxially arranged with the feed screw shaft 22. The motor 44 is configured to drive the feed screw shaft 22 to rotate only in the direction in which the nut portion 24 moves to the tip end side of the plunger 20. 
 ナット部24は、略直方体形状に形成されたナット部本体58と、ナット部本体58に設けられたスライド部60を有する。ナット部本体58には、送りねじ軸22が螺合するねじ孔62と、ねじ孔62を両側から挟むようにして形成されて、爪部38が挿通する一対の貫通孔64とが設けられている。ナット部本体58の外面には、例えば、金属材料等で構成された補強カバー66が装着されている。  The nut part 24 has a nut part body 58 formed in a substantially rectangular parallelepiped shape, and a slide part 60 provided on the nut part body 58. The nut body 58 is provided with a screw hole 62 into which the feed screw shaft 22 is screwed, and a pair of through holes 64 formed so as to sandwich the screw hole 62 from both sides and through which the claw portion 38 is inserted. A reinforcement cover 66 made of, for example, a metal material is attached to the outer surface of the nut portion main body 58. 
 スライド部60は、プランジャ20の軸線方向に沿って伸びた案内壁68に添ってスライドする。図3に示すように、使用前の状態では、ナット部24はプランジャ20に接触しない初期位置にあり、送りねじ軸22の回転作用で初期位置から移動し、プランジャ20に接触してプランジャ20を先端側に押圧する。  The slide part 60 slides along a guide wall 68 extending along the axial direction of the plunger 20. As shown in FIG. 3, in the state before use, the nut portion 24 is in the initial position where it does not come into contact with the plunger 20, and is moved from the initial position by the rotation action of the feed screw shaft 22, and comes into contact with the plunger 20 to move the plunger 20. Press on the tip side. 
 図2に示すように、リユース部14は、ベース部16の開口を閉塞する蓋体70と、蓋体70に設けられた制御部72を備える。制御部72には、ナット部24の初期位置を検出するセンサ(初期位置検出センサ)74と、ナット部24が所定位置に到達したことを検出するセンサ(所定位置検出センサ)76と、アラート部78と、図3に示す駆動部40が設けられている。所定位置検出センサ76は、筒体18内の薬液の残量を検出する。そして、所定位置検出センサ76は、筒体18内の薬液が所定量以下(例えば、50U以下)になったときに、アラート部78を作動させる残量スイッチとして機能する。すなわち、所定位置検出センサ76は、ナット部24が、筒体18内の薬液が所定量になる所定位置まで移動したときに、ナット部24に接触する接触センサである。 As shown in FIG. 2, the reuse unit 14 includes a lid body 70 that closes the opening of the base portion 16, and a control unit 72 provided on the lid body 70. The control unit 72 includes a sensor (initial position detection sensor) 74 that detects the initial position of the nut unit 24, a sensor (predetermined position detection sensor) 76 that detects that the nut unit 24 has reached a predetermined position, and an alert unit. 78 and the drive unit 40 shown in FIG. The predetermined position detection sensor 76 detects the remaining amount of the chemical liquid in the cylindrical body 18. Then, the predetermined position detection sensor 76 functions as a remaining amount switch that operates the alert unit 78 when the amount of the chemical liquid in the cylindrical body 18 becomes a predetermined amount or less (for example, 50 U or less). That is, the predetermined position detection sensor 76 is a contact sensor that comes into contact with the nut portion 24 when the nut portion 24 moves to a predetermined position where the chemical liquid in the tubular body 18 reaches a predetermined amount.
 初期位置検出センサ74は、ナット部24を移動させる前の状態でナット部24が初期位置にあるか否かを検出する。具体的には、初期位置検出センサ74は、リユース部14をディスポ部12に装着したときに、初期位置にあるナット部24が接触する接触センサである。この初期位置検出センサ74によりナット部24が初期位置にあるか否かを容易に検出することが可能になる。なお、接触センサはあくまでも一例であって、初期位置検出センサ74及び所定位置検出センサ76を非接触センサとして構成することも可能である。  The initial position detection sensor 74 detects whether or not the nut portion 24 is in the initial position before moving the nut portion 24. Specifically, the initial position detection sensor 74 is a contact sensor with which the nut part 24 at the initial position comes into contact when the reuse part 14 is attached to the disposable part 12. The initial position detection sensor 74 can easily detect whether or not the nut portion 24 is at the initial position. The contact sensor is merely an example, and the initial position detection sensor 74 and the predetermined position detection sensor 76 can be configured as non-contact sensors. 
 このように、所定位置検出センサ76を接触または非接触センサとして構成することにより、ナット部24が所定位置(薬液の残量アラートを発する位置)に来たか否かを容易に検出することができる。また、初期位置検出センサ74及び所定位置検出センサ76はリユース部14に設けているが、初期位置検出センサ74及び所定位置検出センサ76の両方またはいずれか一方をディスポ部12側に設けるようにしてもよい。  As described above, by configuring the predetermined position detection sensor 76 as a contact or non-contact sensor, it is possible to easily detect whether or not the nut portion 24 has reached a predetermined position (a position for issuing a chemical solution remaining amount alert). .. Further, although the initial position detection sensor 74 and the predetermined position detection sensor 76 are provided in the reuse unit 14, both or one of the initial position detection sensor 74 and the predetermined position detection sensor 76 is provided on the disposable unit 12 side. Good. 
 報知部としてのアラート部78は、一種類のアラート音だけを出力するようにしてもよいが、複数種類のアラート音を出力するようにすることもできる。その場合には、音の周波数、振幅、出力時間あるいは出力回数の少なくとも1つを異ならせるようにすればよい。なお、アラート部78は、必ずしも必要ではなく、残量アラートを音声で発生される代わりに、図1に示した、リモートコントローラ200または端末装置300の表示部200b、300bに薬液の残量が少なくなったことを表示するようにしてもよい。  The alert unit 78 as a notification unit may output only one type of alert sound, but it may also output multiple types of alert sounds. In that case, at least one of the frequency, the amplitude, the output time, and the output frequency of the sound may be made different. It should be noted that the alert unit 78 is not always necessary, and the remaining amount of the liquid medicine is low on the display units 200b and 300b of the remote controller 200 or the terminal device 300 shown in FIG. You may also display that it has become. 
<薬液投与装置の動作/作用の説明> 
 本発明に用いられる薬液投与装置100は、上記のように構成されるものであり、次にその動作並びに作用について説明する。
 ユーザ(患者)が包装容器からディスポ部12を取り出した状態では、ディスポ部12の筒体18内に薬液は充填されていない。このとき、ナット部24はプランジャ20に接触しない初期位置にある。 
<Explanation of operation/action of drug administration device>
The drug solution administration device 100 used in the present invention is configured as described above, and its operation and action will be described below.
In the state where the user (patient) takes out the disposable part 12 from the packaging container, the drug solution is not filled in the cylindrical body 18 of the disposable part 12. At this time, the nut portion 24 is in the initial position where it does not contact the plunger 20.
 次に、ユーザ(患者)は、筒体18に対するプランジャ20の位置を調節し、薬液が密閉保存されている薬液容器から筒体18内に適切な量の薬液を充填する。そして、リユース部14をディスポ部12に装着する。これにより、リユース部14のギヤボックス46の出力歯車48がディスポ部12の平歯車50に噛み合い、ディスポ部12の電池42から電力がリユース部14の構成部品に供給される。
 制御部72は、この電池42の電力により起動され、初期位置検出センサ74により、ナット部24が初期位置にあることを検出する。なお、ディスポ部12は、使用済みのものではなく、未使用品であるとする。
Next, the user (patient) adjusts the position of the plunger 20 with respect to the cylinder 18 and fills the cylinder 18 with an appropriate amount of the drug solution from the drug solution container in which the drug solution is hermetically stored. Then, the reuse section 14 is attached to the disposable section 12. As a result, the output gear 48 of the gear box 46 of the reuse section 14 meshes with the spur gear 50 of the disposal section 12, and the battery 42 of the disposal section 12 supplies electric power to the components of the reuse section 14.
The control unit 72 is activated by the electric power of the battery 42, and the initial position detection sensor 74 detects that the nut unit 24 is at the initial position. It is assumed that the disposable part 12 is not used but is unused.
 次に、ユーザは、薬液投与装置100のプライミングを行う。具体的には、図1に示したリモートコントローラ200を操作して、薬液投与装置100のモータ44を回転駆動させる。すると、モータ44の回転駆動力がギヤボックス46、平歯車50、伝達軸52を介して送りねじ軸22に伝達される。そして、送りねじ軸22が回転し、ナット部24が案内壁68をスライドしながらプランジャ20側に進行する。  Next, the user performs priming of the drug solution administration device 100. Specifically, the remote controller 200 shown in FIG. 1 is operated to rotationally drive the motor 44 of the drug solution administration device 100. Then, the rotational driving force of the motor 44 is transmitted to the feed screw shaft 22 via the gear box 46, the spur gear 50, and the transmission shaft 52. Then, the feed screw shaft 22 rotates, and the nut portion 24 advances toward the plunger 20 side while sliding on the guide wall 68. 
 ナット部24がプランジャ20の先端側に進行すると、一対の爪部38がナット部24の貫通孔64に挿通し、一対の延出部36が互いに近接するように撓む。爪部38が貫通孔64を通り抜けると、爪部38は元の位置に復帰し、ナット部24がプランジャ20に対して係止される。これにより、ナット部24は、プランジャ20の先端側を押圧できるようになる。そして、さらに、ナット部24を進行させることにより、筒体18内の薬液がプランジャ20に押圧されて導出管29の内孔が薬液で満たされてプライミングが完了する。  When the nut portion 24 advances toward the tip end side of the plunger 20, the pair of claw portions 38 are inserted into the through holes 64 of the nut portion 24, and the pair of extending portions 36 bend so as to be close to each other. When the pawl portion 38 passes through the through hole 64, the pawl portion 38 returns to its original position and the nut portion 24 is locked to the plunger 20. As a result, the nut portion 24 can press the tip side of the plunger 20. Then, by further advancing the nut portion 24, the chemical liquid in the cylindrical body 18 is pressed by the plunger 20 and the inner hole of the outlet pipe 29 is filled with the chemical liquid, and the priming is completed. 
 その後、ユーザは、不図示のクレードルを皮膚の所定位置に貼着して、穿刺機構を用いてクレードルに係止されているカニューレを生体内に留置させる。薬液投与装置100をクレードルに接続すると、導出管29とカニューレが連通し、制御部72にある不図示のモータ制御部がモータ44を回転制御することにより筒体18内の薬液が生体内に持続的または間欠的に投与される。  After that, the user attaches a cradle (not shown) to a predetermined position on the skin, and uses the puncture mechanism to leave the cannula locked in the cradle in the living body. When the drug solution administration device 100 is connected to the cradle, the lead-out tube 29 and the cannula communicate with each other, and the motor control unit (not shown) in the control unit 72 controls the rotation of the motor 44 so that the drug solution in the tubular body 18 is maintained in the living body. Administered intermittently or intermittently. 
 そして、所定位置検出センサ76は、初期位置から移動したナット部24が所定位置(筒体18内の薬液の残量アラートを発する位置)に来たことを検出する。すなわち、ナット部24が所定位置に来ると、所定位置検出センサ76がONになり、アラート部78からアラート音が出力される。
 または、リモートコントローラ200の表示部200bの表示画面に残量アラートが表示される。ここでは、図4に示すように、「リザーバーの残量低下 のこり50Uです」といった表示がなされる。これにより、ユーザは、筒体18内の薬液の残量が所定量(例えば、50U)になったことを知ることができる。そして、所定量よりも多い量の薬液を間欠的に投与する場合には、ディスポ部12を未使用品に交換する等の処置をとることができる。 
Then, the predetermined position detection sensor 76 detects that the nut portion 24 moved from the initial position has arrived at a predetermined position (a position for issuing an alert of the remaining amount of the chemical liquid in the tubular body 18). That is, when the nut portion 24 reaches the predetermined position, the predetermined position detection sensor 76 is turned on and the alert sound is output from the alert portion 78.
Alternatively, the remaining amount alert is displayed on the display screen of the display unit 200b of the remote controller 200. Here, as shown in FIG. 4, a display such as "The remaining amount of the remaining amount of the reservoir is 50U" is displayed. As a result, the user can know that the remaining amount of the chemical liquid in the cylindrical body 18 has reached a predetermined amount (for example, 50 U). Then, in the case of intermittently administering the liquid medicine in an amount larger than the predetermined amount, it is possible to take measures such as exchanging the disposable part 12 with an unused product.
<本発明の実施形態例としての薬液投与装置の動作>
 以上説明した点は、既に特許文献1に開示されている技術であるが、本発明の実施形態例の薬液投与装置100は、さらに、筒体18内の薬液のアラートする残量を、ユーザの体重(大人と小児の違い)や状態に応じて、ソフトウェア的に変更できるようにした点に特徴がある。以下、図5~図7を参照して、本発明の実施形態例である薬液投与装置100の動作について説明する。 
<Operation of the drug solution administration device as the embodiment of the present invention>
The point described above is the technology already disclosed in Patent Document 1, but the drug solution administration device 100 according to the embodiment of the present invention further sets the remaining amount of the drug solution in the tubular body 18 for alerting the user. The feature is that the software can be changed according to the weight (difference between adult and child) and condition. Hereinafter, with reference to FIG. 5 to FIG. 7, the operation of the drug solution administration device 100 according to the embodiment of the present invention will be described.
 まず、本発明の実施形態例では、設定した基礎レートパターンの一日の総投与量から、通常、薬液の残量がアラートされる値(例えば、50U)の残量スイッチ(図2の所定位置検出センサ76)を使うか否かが判断される。そして、50Uの残量スイッチを使わないと判断された場合、つまり、残量アラートを発する値が50U以下の場合には、50U以下の薬液の残量Xをソフトウェア的に設定し、薬液の残量がXになったときに残量アラートを通知するようにする。なお、残量アラートを出す残量を50Uとした点は、あくまでも一例であり、このアラートを発する残量値は、患者のプロファイルに応じて所定の値(以下、「所定値」)に設定される。 First, in the embodiment of the present invention, the remaining amount switch (a predetermined position in FIG. 2) of a value (for example, 50 U) that usually alerts the remaining amount of the liquid medicine from the total daily dose of the set basal rate pattern is set. It is determined whether or not the detection sensor 76) is used. When it is determined that the 50U remaining amount switch is not used, that is, when the value for issuing the remaining amount alert is 50U or less, the remaining amount X of the chemical liquid of 50U or less is set by software, and the remaining amount of the chemical liquid is set. The remaining amount alert is notified when the amount reaches X. The point that the remaining amount of the remaining amount alert is set to 50 U is merely an example, and the remaining amount value of this alert is set to a predetermined value (hereinafter, “predetermined value”) according to the profile of the patient. It
 図5Aは、例として、コントローラ200に保存されている基礎レート投与を設定する際の3つのパターン1~3を示している。パターン1は、通常の平日の基礎レート投与を選定するパターンである。パターン2は、患者が運動したときの基礎レート投与パターンであり、この場合は、平常時よりも少ない投与量となる。パターン3は、ユーザが病気の状態のときの基礎レート投与パターンであり、この場合には個々のユーザによって投与量が異なってくる。 FIG. 5A shows, as an example, three patterns 1 to 3 in setting the basal rate administration stored in the controller 200. Pattern 1 is a pattern for selecting a normal weekday basal rate administration. Pattern 2 is a basal rate administration pattern when the patient is exercising, and in this case, the dose is smaller than in normal times. Pattern 3 is a basal rate administration pattern when the user is ill, and in this case, the dose varies depending on the individual user.
 いずれの基礎レート投与パターンでも、大人と小児、あるいは太っている人とやせている人では、一日の総投与量が異なるため、予め設定した基礎レート投与パターン1~3の中からユーザのプロファイルに応じて基礎レート投与パターンを選択する。なお、基礎レート投与パターンは、図5Aに示した3つのパターンに限定されない。他にユーザである患者の体重差などにより設定を変更することもできる。基礎レート投与パターンの変更は、リモートコントローラ200の表示画面(図5A)のいずれかをタッチすることによって行われる。 In any of the basal rate administration patterns, the total daily dose differs between adults and children, or fat and thin people. Therefore, the user's profile is selected from preset basal rate administration patterns 1 to 3. The basal rate dosing pattern is selected according to. The basal rate administration pattern is not limited to the three patterns shown in FIG. 5A. In addition, the setting can be changed depending on the weight difference of the user who is the user. The basal rate administration pattern is changed by touching any of the display screens (FIG. 5A) of the remote controller 200.
 平均的な体重の大人であれば、通常は、筒体18内に充填される3日分の薬液の満量は200U程度であり、残量が4分の1の50Uになったときに、残量アラートを発するように設定される。この値は、大人であっても体重の多少により、変化する値である。また、小児の場合には、体重の多少にも関係するが、3日間で総投与する薬液の量は通常60U程度に設定される。 For an adult of average weight, normally, the full amount of the drug solution for three days filled in the cylindrical body 18 is about 200 U, and when the remaining amount becomes 50 U which is a quarter, It is set to issue a remaining amount alert. This value is a value that changes depending on the weight of an adult. In the case of children, the total amount of drug solution to be administered in 3 days is usually set to about 60 U, though it depends on the weight.
 すなわち、小児であれば、基礎レートの1日の総投与量が10.20U、ディスポ部12の交換頻度が3日に1回、ボーラス量を含めたマージンを2倍とすると、3日間の総投与量は、以下の通りになる。
  10.20[U] ×3[日]×2[倍]=61.2[U] 
 この3日分の総投与量61.2Uの4分の1で残量アラートを発するように設定した場合、
  61.2[U]÷4=15.3[U] 
 になり、薬液の残量が15.3Uになったときに、残量アラートを発するようにすればよい。つまり、通常の大人の設定値である50Uより、小さい値を残量アラート値として設定する必要がある。 
In other words, for children, if the total daily dose at the basal rate is 10.20 U, the frequency of replacement of the disposable part 12 is once every three days, and the margin including the bolus amount is doubled, the total daily dose will be three days. The dose is as follows.
10.20 [U] x 3 [days] x 2 [times] = 61.2 [U]
When it is set to issue the remaining amount alert with a quarter of the total dose of 61.2 U for these three days,
61.2 [U]/4=15.3 [U]
Then, when the remaining amount of the chemical solution reaches 15.3 U, a remaining amount alert may be issued. That is, it is necessary to set a value smaller than the usual adult setting value of 50 U as the remaining amount alert value.
<本発明の実施形態例の薬液投与装置の機能説明>
 図6は、本発明の実施形態例の薬液投与装置(ポンプ本体)100と、リモートコントローラ200の機能を示すブロック図である。
 薬液投与装置100は、電源部101、駆動部102、残量検出部103、出力部104、日時管理部105、データ記憶部106、本体通信部107、及びこれらを制御する本体演算部108を備える。
<Functional explanation of the drug solution administration device according to the embodiment of the present invention>
FIG. 6 is a block diagram showing the functions of the drug solution administration device (pump body) 100 and the remote controller 200 according to the embodiment of the present invention.
The drug solution administration device 100 includes a power supply unit 101, a drive unit 102, a remaining amount detection unit 103, an output unit 104, a date/time management unit 105, a data storage unit 106, a main body communication unit 107, and a main body calculation unit 108 that controls these. ..
 電源部101は、薬液投与装置100を構成する各構成要素に電力を供給するためのものであり、例えば図2、図3に示す電池42及びこれを収納する不図示の電池ボックス、さらには電池42からの電力の供給をオン/オフする不図示のスイッチなどで構成される。 The power supply unit 101 is for supplying electric power to each constituent element of the chemical liquid administration device 100, and includes, for example, the battery 42 shown in FIGS. 2 and 3, a battery box (not shown) that houses the battery 42, and a battery. It is composed of a switch (not shown) for turning on/off the power supply from 42.
 駆動部102は、薬液投与装置100を装着した患者に対して薬液投与を実施するためのものであり、図3の駆動部40に相当する。すなわち、図2、図3で述べたように、駆動部102は、投与する薬液を収容する筒体18、筒体18内において摺動される押し子32、押し子32を移動させるためのモータ44及びギヤボックス46等で構成される。 The drive unit 102 is for performing drug solution administration to a patient wearing the drug solution administration device 100, and corresponds to the drive unit 40 in FIG. 3. That is, as described with reference to FIGS. 2 and 3, the drive unit 102 includes the cylinder 18 for containing the liquid medicine to be administered, the pusher 32 slid in the cylinder 18, and the motor for moving the pusher 32. 44 and a gear box 46 and the like.
 残量検出部103は、残量スイッチ(図2、図3の所定位置検出センサ76)と不図示のカウンタ部で構成される。カウンタ部は、モータ44の回転数をカウントする。残量検出部103は、所定位置検出センサ76によりアラートを行うべき所定量(例えば、50U)の薬液の残量が検出されると、本体演算部108に検出信号を出力する。そして、本体演算部108は、アラート部78を作動させて警報音を発生させる。あるいは本体通信部107を介してリモートコントローラ200にアラートを告げる信号が送られ、リモートコントローラ200の表示部200bの表示画面上に、例えば、図4に示されるような「リザーバーの残量低下 のこり50Uです」といった表示がなされる。 The remaining amount detection unit 103 includes a remaining amount switch (predetermined position detection sensor 76 in FIGS. 2 and 3) and a counter unit (not shown). The counter unit counts the number of rotations of the motor 44. The remaining amount detection unit 103 outputs a detection signal to the main body calculation unit 108 when the predetermined position detection sensor 76 detects the remaining amount of a predetermined amount (for example, 50 U) of the chemical liquid to be alerted. Then, the main body calculation unit 108 activates the alert unit 78 to generate an alarm sound. Alternatively, a signal for sending an alert is sent to the remote controller 200 via the main body communication unit 107, and, for example, on the display screen of the display unit 200b of the remote controller 200, for example, as shown in FIG. Is displayed."
 また、残量検出部103は、カウンタ部がカウントしたモータ44の回転数を本体演算部108に出力する。本体演算部108は、残量検出部103から出力されたモータ44の回転数に基づいて薬液の残量をカウントする。 Further, the remaining amount detection unit 103 outputs the rotation speed of the motor 44 counted by the counter unit to the main body calculation unit 108. The main body calculation unit 108 counts the remaining amount of the chemical liquid based on the rotation speed of the motor 44 output from the remaining amount detection unit 103.
 但し、このアラートを発するのは、あくまでも3日分の総投与量の4分の1になる薬液の量が50U以上のときである。3日分の総投与量の4分の1になる薬液の量が50U未満のときは、所定位置検出センサ76の位置が検出されても、アラートを発することなく、不図示のカウンタ部により、筒体18内の薬液の残量がカウントされる。この薬液の残量のカウントは、モータ44の回転数を不図示のエンコーダでカウントすることにより行われる。 However, this alert is issued only when the amount of drug solution, which is a quarter of the total dose for 3 days, is 50 U or more. When the amount of the drug solution that is a quarter of the total dose for 3 days is less than 50 U, even if the position of the predetermined position detection sensor 76 is detected, an alert is not issued and a counter unit (not shown) The remaining amount of the chemical liquid in the cylindrical body 18 is counted. The remaining amount of the chemical liquid is counted by counting the number of rotations of the motor 44 with an encoder (not shown).
 そして、筒体18内の薬液の残量が、アラートを発する残量アラート値Xに一致した時点で、薬液投与装置100の本体演算部108は、本体通信部107を介して、リモートコントローラ200にアラートを表示するための信号を送る。この薬液投与装置100からのアラート信号を受けて、リモートコントローラ200のコントローラ演算部208は、表示部204の表示画面にアラート、例えば、図4に類似する「リザーバーの残量低下 のこりXです」といった表示を行う。 Then, when the remaining amount of the liquid medicine in the cylindrical body 18 matches the remaining amount alert value X for issuing an alert, the main body calculation unit 108 of the liquid medicine administration device 100 transfers the remote controller 200 to the remote controller 200 via the main body communication unit 107. Send a signal to display an alert. In response to the alert signal from the liquid medicine administration device 100, the controller operation unit 208 of the remote controller 200 alerts the display screen of the display unit 204, for example, "remaining low amount of the reservoir X is X". Display.
 報知部としての出力部104は、例えば図2に示すアラート部78であり、常時は、薬液投与装置100とリモートコントローラ200との通信が途絶えたときに、本体演算部108からの指示により警報を出力する。この警報としては、振動または音などを単独で、または併用してもよいし、光を発するものであってもよい。 The output unit 104 as a notification unit is, for example, the alert unit 78 shown in FIG. 2, and normally, when communication between the chemical solution administration device 100 and the remote controller 200 is interrupted, an alarm is issued by an instruction from the main body calculation unit 108. Output. As the alarm, vibration or sound may be used alone or in combination, or may emit light.
 日時管理部105は、日時管理を行うプログラム機能であり、日時情報を出力するために、一般的なマイクロコンピュータに搭載されている機能である。この日時管理部105は、電源がオフの状態であっても電力が供給されるので、正確な日時情報を出力することができる。 The date and time management unit 105 is a program function for performing date and time management, and is a function installed in a general microcomputer to output date and time information. Since the date and time management unit 105 is supplied with power even when the power is off, it is possible to output accurate date and time information.
 データ記憶部106には、薬液投与装置100を制御する各種データが記憶されるが、このデータの中には、リモートコントローラ200において、患者の基礎レート投与パターンに基づいて、計算されたアラートを発する薬液の残量アラート値Xが含まれる。他にも、例えばコントローラ忘れ防止機能データ、自動ボーラス投与データ、投与履歴データ、基本レート投与データ(ベーサル投与データ)、及びペアリング用データ等がある。なお、これらのデータについては、本実施形態例との直接的な関係はなく、また先行特許文献である特開2017-148393公報に詳細に記載されているので説明は省略する。 The data storage unit 106 stores various data for controlling the drug solution administration device 100. In the data, the remote controller 200 issues an alert calculated based on the basal rate administration pattern of the patient. The alert value X of the remaining amount of the chemical liquid is included. In addition, for example, controller forget prevention function data, automatic bolus administration data, administration history data, basic rate administration data (basal administration data), data for pairing, and the like. Note that these data have no direct relationship with the present embodiment and are described in detail in Japanese Unexamined Patent Application Publication No. 2017-148393, which is a prior patent document, and therefore description thereof will be omitted.
 本体通信部107は、薬液投与装置100とリモートコントローラ200との間で無線通信を行う。本体通信部107は送信部と受信部とを有し、所定の波長帯域の電波、例えば極超短波またはマイクロ波を使った無線通信を行う。この本体通信部107は、本体演算部108からの指示により、ペアリングされたリモートコントローラ200におけるコントローラ通信部207との間で信号の送受信を行い、コントローラ通信部207との間での通信を確立する。 The main body communication unit 107 performs wireless communication between the drug solution administration device 100 and the remote controller 200. The main body communication unit 107 has a transmission unit and a reception unit, and performs radio communication using radio waves in a predetermined wavelength band, for example, ultrashort waves or microwaves. The main body communication unit 107 transmits/receives a signal to/from the controller communication unit 207 in the paired remote controller 200 according to an instruction from the main body calculation unit 108 to establish communication with the controller communication unit 207. To do.
 本体演算部108は、本体通信部107で受信した各種のデータをデータ記憶部106に記憶する。また本体演算部108は、リモートコントローラ200から送信された信号に基づいて、駆動部102を駆動し、また出力部104から警報を出力する。さらに、本体演算部108は、データ記憶部106に記憶された各種データに基づいて、駆動部102を駆動し、薬液投与装置100を装着したユーザ(患者)に対して、インスリンのベーサル投与及びボーラス投与を制御する。 The main body calculation unit 108 stores various data received by the main body communication unit 107 in the data storage unit 106. Further, the main body arithmetic unit 108 drives the drive unit 102 based on the signal transmitted from the remote controller 200, and outputs an alarm from the output unit 104. Furthermore, the main body calculation unit 108 drives the drive unit 102 based on various data stored in the data storage unit 106, and performs basal insulin administration and bolus of insulin to the user (patient) who wears the drug solution administration device 100. Control dosing.
<リモートコントローラ200の機能説明>
 リモートコントローラ200は、図6に示すように、電源部201、入力部202、出力部203、表示部204、日時管理部205、データ記憶部206、コントローラ通信部207、及びこれらを制御するコントローラ演算部208を備える。
<Explanation of Functions of Remote Controller 200>
As shown in FIG. 6, the remote controller 200 includes a power supply unit 201, an input unit 202, an output unit 203, a display unit 204, a date/time management unit 205, a data storage unit 206, a controller communication unit 207, and a controller operation for controlling them. The unit 208 is provided.
 上記各構成要素のうち、薬液投与装置100の構成要素と同じ機能を持つものは、重複する説明を省略し、薬液投与装置100とは異なる機能を持つ構成要素についてのみ説明を加える。 Among the above-mentioned constituent elements, those having the same function as the constituent elements of the drug solution administration device 100 will be omitted, and only the constituent elements having a different function from the drug solution administration device 100 will be described.
 本実施形態例では、表示部204に、薬液の残量が所定値以下になったときのアラートが表示されるほかに、各種の設定内容、入力部202による入力内容、あるいは薬液投与装置100での投与履歴等が表示される。この表示部204は、例えば液晶ディスプレイを用いて構成されている。なお、図4、図5は、表示部204に表示される表示画面の一例であり、表示部204には、この画面以外にも、薬液投与装置100の動作に用いられる各種データなどが表示される。 In the present embodiment example, in addition to displaying an alert when the remaining amount of the liquid medicine is below a predetermined value, the display unit 204 displays various setting contents, contents input by the input unit 202, or the liquid medicine administration device 100. The administration history, etc. are displayed. The display unit 204 is composed of, for example, a liquid crystal display. 4 and 5 are examples of display screens displayed on the display unit 204. In addition to this screen, the display unit 204 also displays various data used for the operation of the drug solution administration device 100. It
 入力部202は、電源のオンオフ操作、薬液投与装置100によるインスリンの投与の設定、及び表示部204での表示内容等のデータを入力する。入力部202は、例えばキーパッドや、表示部204の前面に設けたタッチパネルで構成される。
 出力部203、日時管理部205、データ記憶部206、コントローラ通信部207の機能は、薬液投与装置100の出力部104,日時管理部105、データ記憶部106、本体通信部107と同様なので、ここでは説明を省略する。
The input unit 202 inputs data such as an on/off operation of a power source, settings of insulin administration by the drug solution administration device 100, and display contents on the display unit 204. The input unit 202 includes, for example, a keypad and a touch panel provided on the front surface of the display unit 204.
The functions of the output unit 203, the date/time management unit 205, the data storage unit 206, and the controller communication unit 207 are the same as those of the output unit 104, the date/time management unit 105, the data storage unit 106, and the main body communication unit 107 of the drug administration device 100. Then, the description is omitted.
 コントローラ演算部208は、入力部202において入力された各種の設定や、アラートを発する薬液の残量アラート値Xを、データ記憶部206に記憶する。そして、アラートを発する薬液の残量アラート値Xを含む、薬液投与装置100側で必要とされるデータを、コントローラ通信部207を介して薬液投与装置100の本体通信部107に送信する。 The controller calculation unit 208 stores the various settings input in the input unit 202 and the remaining amount alert value X of the chemical liquid that issues an alert in the data storage unit 206. Then, the data necessary for the drug solution administration device 100 side, including the alert value X of the remaining amount of the drug solution that issues an alert, is transmitted to the main body communication unit 107 of the drug solution administration device 100 via the controller communication unit 207.
 <本発明の実施形態例の薬液投与方法の手順に係る動作説明>
 図7は、本発明の一実施形態例に係る薬液投与方法の手順を説明するためのフローチャートである。
 図7に示すように、薬液の投与を開始する前に、まず薬液投与の基礎レート投与パターンを選択する(ステップS1)。ステップS1では、図5Aに示されるような、リモートコントローラ200の表示部204に表示される複数の基礎レート投与パターンの中から、患者の状態(プロファイル)に応じて最適な基礎レート投与パターンが選択される。この選択は入力部202によって行われる。
<Explanation of operation relating to procedure of drug solution administration method according to embodiment of the present invention>
FIG. 7 is a flowchart for explaining the procedure of the drug solution administration method according to the embodiment of the present invention.
As shown in FIG. 7, before starting administration of the drug solution, first, a basal rate administration pattern of the drug solution is selected (step S1). In step S1, the optimal basal rate administration pattern is selected according to the patient's condition (profile) from the plurality of basal rate administration patterns displayed on the display unit 204 of the remote controller 200 as shown in FIG. 5A. To be done. This selection is made by the input unit 202.
 そして、コントローラ演算部208は、患者の状態(プロファイル)に応じて、残量アラートを発する際の残量アラート値Xを計算する(ステップS2)。既に述べたように、このアラートを発する残量アラート値Xは、患者が大人であるか、小児であるかによって異なる。また、投薬の時期が平時か、運動時か、あるいは病気時などによっても異なってくるので、基礎レート投与の際にアラートを発する最適な残量アラート値Xを計算する必要がある。なお、このアラートを発するときの残量アラート値Xの計算は、薬液投与装置100の本体演算部108で行うようにしてもよい。 Then, the controller calculation unit 208 calculates the remaining amount alert value X when issuing the remaining amount alert according to the condition (profile) of the patient (step S2). As described above, the remaining amount alert value X for issuing this alert differs depending on whether the patient is an adult or a child. Further, since the timing of medication varies depending on whether it is during normal times, during exercise, or during illness, it is necessary to calculate the optimum remaining amount alert value X that issues an alert during basal rate administration. It should be noted that the calculation of the remaining amount alert value X when issuing this alert may be performed by the main body calculation unit 108 of the drug solution administration device 100.
 この場合、本体演算部108は、データ記憶部106に記憶されている患者に応じた基礎レートの1日の総投与量をベースにして計算する。例えば、既に述べたように、患者が小児であれば、基礎レートの1日の総投与量を10.20U、ディスポ部12の交換頻度を3日に1回、ボーラス量を含めたマージンを2倍として、3日間の総投与量を61.2Uと計算する。そして、この3日分の総投与量61.2Uの4分の1の15.3Uになったとき、すなわち、X=15.3Uで残量アラートを発するように設定する。 In this case, the main body calculation unit 108 calculates based on the total daily dose of the basal rate according to the patient stored in the data storage unit 106. For example, as described above, if the patient is a child, the total daily dose of the basal rate is 10.20 U, the frequency of replacement of the disposable 12 is once every three days, and the margin including the bolus amount is 2 Doubling and calculating a total dose of 61.2 U for 3 days. Then, when the total dose of 31.2 days, which is 61.2 U, is ¼, which is 15.3 U, that is, when X=15.3 U, the remaining amount alert is set to be issued.
 なお、平時における大人の基礎レート投与パターンでは、アラートを発する薬液の残量アラート値Xを、例えば50Uに設定することが一般的であることは、既に説明した通りである。したがって、残量スイッチ(図2の所定位置検出センサ76)の位置は、図3に示すように、残量アラートを発生するか否かにかかわらず、一定の値、例えば残量値が50Uになる位置に設定しておく。 It should be noted that, as described above, it is common to set the residual amount alert value X of the alerting chemical solution to, for example, 50 U in the adult basal rate administration pattern in normal times. Therefore, as shown in FIG. 3, the position of the remaining amount switch (predetermined position detection sensor 76 in FIG. 2) is set to a fixed value, for example, 50 U regardless of whether or not a remaining amount alert is generated. Set to the position.
 次に、本体演算部108は、求められた残量アラート値Xが50U未満であるか否かが判断される(ステップS3)。ステップS3において、残量アラート値Xが50U以上であると本体演算部108が判断した場合には(ステップS3のNO)、薬液投与が開始され(ステップS4)、薬液の残量が所定値50Uになった段階で、残量アラートを発するための残量スイッチが使用される(ステップS5)。なお、ステップS4とステップS5は、この順序である必要はない。ステップS5の「残量スイッチの使用」をステップS4の「薬液投与開始」の前に持って来てもさしつかえない。 Next, the main body calculation unit 108 determines whether or not the calculated remaining amount alert value X is less than 50 U (step S3). In step S3, when the main body calculation unit 108 determines that the remaining amount alert value X is 50 U or more (NO in step S3), the liquid medicine administration is started (step S4), and the remaining amount of the liquid medicine is the predetermined value 50U. When it becomes, the remaining amount switch for issuing the remaining amount alert is used (step S5). Note that step S4 and step S5 do not have to be in this order. It does not matter if the "use of the remaining amount switch" in step S5 is brought before the "start of drug solution administration" in step S4.
 そして、患者への薬液の投与が行われ、図3のスライド部60が移動して、残量スイッチが押下されたか否かが本体演算部108によって判断される(ステップS6)。ステップS6で残量スイッチが押下されなければ(ステップS6のNO)、押下されるまで待機する。ステップS6で残量スイッチが押下された場合(ステップS6のYES)、残量検出部103から検出信号が本体演算部108に出力される。そして、本体演算部108は、残量アラート信号を出力部104や、リモートコントローラ200に出力する。出力部104や、リモートコントローラ200の出力部203や表示部204は、筒体18内の薬液の残量値が所定値50Uになったことを患者に対して残量アラートとして通知し(ステップS7)、処理を終了する。 Then, the drug solution is administered to the patient, the slide unit 60 of FIG. 3 moves, and the main body operation unit 108 determines whether or not the remaining amount switch is pressed (step S6). If the remaining amount switch is not pressed in step S6 (NO in step S6), the process waits until it is pressed. When the remaining amount switch is pressed in step S6 (YES in step S6), the remaining amount detection unit 103 outputs a detection signal to the main body calculation unit 108. Then, the main body calculation unit 108 outputs the remaining amount alert signal to the output unit 104 and the remote controller 200. The output unit 104, the output unit 203 of the remote controller 200, and the display unit 204 notify the patient as a remaining amount alert that the remaining amount value of the drug solution in the cylindrical body 18 has reached the predetermined value 50U (step S7). ), the processing ends.
 次に、ステップS3で、計算された残量アラート値Xが所定値50U未満であると判断された場合には(ステップS3のYES)、本体演算部108は、残量アラートを発する値を残量アラート値Xに設定し(ステップS8)、薬液投与を開始する(ステップS9)。
 その後、薬液の投与が進むと、本体演算部108はスライド部60により残量スイッチが押下されたか否かを判断する(ステップS10)。このステップS10の判断は、アラートを発する残量アラート値Xが50U未満のときには、必ずしも必要とされないものである。ここでは、残量スイッチが押下されても、残量アラートは発生されない。
Next, when it is determined in step S3 that the calculated remaining amount alert value X is less than the predetermined value 50U (YES in step S3), the main body calculation unit 108 leaves the value for issuing the remaining amount alert. The amount alert value X is set (step S8), and administration of the liquid medicine is started (step S9).
After that, when the administration of the liquid medicine progresses, the main body calculation unit 108 determines whether or not the remaining amount switch is pressed by the slide unit 60 (step S10). The determination in step S10 is not always necessary when the remaining amount alert value X for issuing an alert is less than 50U. Here, even if the remaining amount switch is pressed, the remaining amount alert is not generated.
 つまり、残量スイッチは単に所定位置検出スイッチとして用いられるものであるから、残量スイッチの位置は、残量アラートを発するか否かにかかわらず、常に、図3のスライド部60がスライドする案内壁68の所定位置(薬液の残量が50Uの位置)にセットされている。したがって、アラートを発生する残量アラート値Xが50U未満であれば、残量スイッチが押下されても、残量アラート信号は出力されない。 That is, since the remaining amount switch is merely used as a predetermined position detection switch, the position of the remaining amount switch is always guided by the sliding portion 60 of FIG. 3 regardless of whether or not a remaining amount alert is issued. The wall 68 is set at a predetermined position (position where the remaining amount of the chemical liquid is 50 U). Therefore, if the remaining amount alert value X for generating an alert is less than 50 U, the remaining amount alert signal is not output even if the remaining amount switch is pressed.
 ステップS10で、残量スイッチが押下されると(ステップS10のYES)、本体演算部108は、残量スイッチが押された後の筒体18内の薬液の残量のカウントを開始する(ステップS11)。このカウントは、例えば、残量検出部103のカウンタ部によってモータ44の回転数に基づいて行われる。または、残量検出部103のカウンタ部がカウントしたモータ44の回転数から、プランジャ20の移動量を算出し、薬液の残量をカウントしてもよい。なお、カウンタ部としてモータ44の回転数をカウントする例を説明したが、これに限定されるものではなく、カウンタ部として送りねじ軸22の回転数をカウントしてもよいし、プランジャ20の移動量を直接カウントしてもよい。 When the remaining amount switch is pressed in step S10 (YES in step S10), the main body calculation unit 108 starts counting the remaining amount of the chemical liquid in the tubular body 18 after the remaining amount switch is pressed (step S10). S11). This counting is performed, for example, by the counter unit of the remaining amount detecting unit 103 based on the number of rotations of the motor 44. Alternatively, the amount of movement of the plunger 20 may be calculated from the number of rotations of the motor 44 counted by the counter unit of the remaining amount detecting unit 103, and the remaining amount of the chemical liquid may be counted. Although an example of counting the number of rotations of the motor 44 as the counter unit has been described, the present invention is not limited to this, and the number of rotations of the feed screw shaft 22 may be counted as the counter unit, or the movement of the plunger 20 may be performed. The amount may be counted directly.
 次に、本体演算部108は、ステップS11の残量カウント値が、アラートを発する残量アラート値Xに等しくなったか否かを判断する(ステップS12)。ここで、残量カウント値とは、残量スイッチの位置での残量(50U)から、残量検出部103のカウンタ部がカウントしたモータ44の回転数に基づいて算出した薬液量、すなわち、残量スイッチを押下した後に送液した薬液量を減じた値となる。ステップS12の処理は、残量カウント値が、アラートを発する残量アラート値Xになるまで繰り返される(ステップS12のNO)。そして、ステップS12で、残量カウント値がアラートを発する残量アラート値Xになったとき(ステップS12のYES)に、薬液投与装置100の本体演算部108は、残量アラート信号を出力部104や、リモートコントローラ200に出力する。これにより、アラート部78によりアラート音を発生させるか、あるいは本体通信部107を経由して、リモートコントローラ200の表示部204に残量アラートが表示され、患者に対して残量アラートが通知される(ステップS7)。 Next, the main body calculation unit 108 determines whether or not the remaining amount count value in step S11 is equal to the remaining amount alert value X for issuing an alert (step S12). Here, the remaining amount count value is the amount of chemical liquid calculated from the remaining amount (50 U) at the position of the remaining amount switch based on the rotation speed of the motor 44 counted by the counter unit of the remaining amount detecting unit 103, that is, The value is the value obtained by subtracting the amount of the chemical solution sent after pressing the remaining amount switch. The process of step S12 is repeated until the remaining amount count value reaches the remaining amount alert value X for issuing an alert (NO in step S12). Then, in step S12, when the remaining amount count value reaches the remaining amount alert value X for issuing an alert (YES in step S12), the main body calculation unit 108 of the drug administration device 100 outputs the remaining amount alert signal to the output unit 104. Or output to the remote controller 200. Accordingly, the alert sound is generated by the alert unit 78, or the remaining amount alert is displayed on the display unit 204 of the remote controller 200 via the main body communication unit 107, and the remaining amount alert is notified to the patient. (Step S7).
 図7の例では、ステップS9の薬液投与開始後に、残量スイッチが押下されてから、ステップS11の残量カウントを開始している。しかし、残量アラートを発する残量アラート値Xが所定値50U未満の場合には、残量スイッチの押下と関係なく、残量カウントの開始を行うことも可能である。
 例えば、ステップS9の薬液投与開始のタイミングでステップS11の残量カウントを開始することもできる。ただし、この場合、導入ポート26から筒体18内へ充填した薬液の満量を正確に知る必要がある。なぜなら、薬液の満量は、ユーザ毎に、また同じユーザでもプロファイルによって異なるからである。また、筒体18内の気泡を除去した場合に、正確な満量を知ることも難しくなるからである。
In the example of FIG. 7, the remaining amount switch is pressed after the start of the chemical liquid administration in step S9, and then the remaining amount counting in step S11 is started. However, when the remaining amount alert value X for issuing the remaining amount alert is less than the predetermined value 50U, it is possible to start the remaining amount count regardless of the pressing of the remaining amount switch.
For example, the remaining amount count in step S11 can be started at the timing of starting the liquid medicine administration in step S9. However, in this case, it is necessary to accurately know the full amount of the liquid medicine filled from the introduction port 26 into the cylindrical body 18. This is because the full amount of drug solution varies depending on the user and the profile of the same user. Also, it is difficult to know the exact full amount when the bubbles in the tubular body 18 are removed.
 以上、本発明の実施形態例について説明したが、本発明の薬液投与装置及び薬液投与方法は、ここで説明した実施形態に限らず、請求の範囲に記載した本発明の要旨を逸脱しない範囲で種々の変更が可能である。例えば、図6では、薬液投与装置100とリモートコントローラ200をネットワークで接続する構成として示しているが、コントローラ200の構成を薬液投与装置200に組み込んで、これらを一体化した薬液投与装置とすることもできる。 Although the embodiment example of the present invention has been described above, the chemical solution administration device and the chemical solution administration method of the present invention are not limited to the embodiment described herein, and are within the scope of the present invention described in the claims. Various changes are possible. For example, in FIG. 6, the chemical solution administration device 100 and the remote controller 200 are shown as connected to each other via a network, but the configuration of the controller 200 is incorporated into the chemical solution administration device 200 to form an integrated chemical solution administration device. Can also
 上述した実施形態例では、薬液投与装置としてインスリンを投与するインスリンポンプを適用した例を説明したが、これに限定されるものではない。投与する薬液としては、鎮痛剤、抗癌治療薬、HIV薬、鉄キレート薬、肺高血圧症治療薬等のその他各種の薬液を用いてもよい。 In the above-described embodiment, an example in which an insulin pump that administers insulin is applied as the drug solution administration device has been described, but the invention is not limited to this. As the drug solution to be administered, various other drug solutions such as analgesics, anti-cancer therapeutic agents, HIV drugs, iron chelating agents, pulmonary hypertension therapeutic agents and the like may be used.
 1…薬液投与支援システム、100…薬液投与装置(ポンプ本体)、200…リモートコントローラ、300…端末装置、12…ディスポ部、14…リユース部、16…ベース部、18…筒体、20…プランジャ、26…導入ポート、28…導出ポート、24…ナット部、40…駆動部、42…電池、52…伝達軸、60…スライド部、22…送りねじ軸、70…蓋体、72…制御部、78…アラート部、76…所定位置検出センサ(残量スイッチ)、74…初期位置検出センサ、 101、201…電源部、102…駆動部、103…残量検出部、104、203…出力部、105、205…日時管理部、106、206…データ記憶部、107…本体通信部、108…本体演算部、202…入力部、204…表示部、207…コントローラ通信部、208…コントローラ演算部 DESCRIPTION OF SYMBOLS 1... Chemical liquid administration support system, 100... Chemical liquid administration device (pump main body), 200... Remote controller, 300... Terminal device, 12... Disposable part, 14... Reuse part, 16... Base part, 18... Cylindrical body, 20... Plunger , 26... Introduction port, 28... Outflow port, 24... Nut part, 40... Drive part, 42... Battery, 52... Transmission shaft, 60... Slide part, 22... Feed screw shaft, 70... Lid body, 72... Control part , 78... Alert unit, 76... Predetermined position detection sensor (remaining amount switch), 74... Initial position detection sensor, 101, 201... Power supply unit, 102... Driving unit, 103... Remaining amount detection unit, 104, 203... Output unit , 105, 205... Date/time management section, 106, 206... Data storage section, 107... Main body communication section, 108... Main body calculation section, 202... Input section, 204... Display section, 207... Controller communication section, 208... Controller calculation section

Claims (8)

  1.  筒体内の薬液の残量が所定値になったときに残量アラートを発する薬液投与装置であって、
     前記薬液の総投与量から残量アラートを発する残量値を計算し、残量アラート信号を出力する演算部と、
     前記演算部が出力した残量アラート信号に基づいて前記残量アラートを発する報知部と、
     を備え、
     前記演算部は、
     前記計算した前記残量値が所定値以上のときは、前記薬液の残量が前記所定値になったときに前記残量アラート信号を前記報知部に出力し、
     前記計算した前記残量値が前記所定値未満のときは、前記薬液の残量をカウントし、そのカウント値が前記計算した前記残量値に達したときに、前記残量アラート信号を前記報知部に出力する、
     薬液投与装置。
    A liquid medicine administration device that issues a remaining amount alert when the amount of liquid medicine in the cylinder reaches a predetermined value,
    A calculation unit that calculates a remaining amount value that issues a remaining amount alert from the total dose of the liquid medicine, and outputs a remaining amount alert signal,
    A notification unit that issues the remaining amount alert based on the remaining amount alert signal output by the calculation unit,
    Equipped with
    The arithmetic unit is
    When the calculated remaining amount value is equal to or more than a predetermined value, the remaining amount alert signal is output to the notification unit when the remaining amount of the chemical liquid reaches the predetermined value,
    When the calculated remaining amount value is less than the predetermined value, the remaining amount of the chemical liquid is counted, and when the count value reaches the calculated remaining amount value, the remaining amount alert signal is notified. Output to
    Drug delivery device.
  2.  前記筒体内の薬液の残量を検出する残量スイッチを設け、
     前記演算部は、前記残量アラート信号を出力する残量値が前記所定値以上のときは、前記残量スイッチを押下したタイミングで前記残量アラート信号を出力する、
     請求項1に記載の薬液投与装置。
    A remaining amount switch is provided to detect the remaining amount of the liquid medicine in the cylinder,
    When the remaining amount value for outputting the remaining amount alert signal is equal to or more than the predetermined value, the arithmetic unit outputs the remaining amount alert signal at the timing of pressing the remaining amount switch,
    The drug solution administration device according to claim 1.
  3.  前記演算部は、前記計算した前記残量アラート信号を出力する前記残量値が前記所定値未満のときには、前記残量スイッチの押下時点から前記薬液の残量のカウントを開始する
     請求項2に記載の薬液投与装置。
    The calculation unit starts counting the remaining amount of the chemical liquid when the remaining amount switch is pressed when the remaining amount value that outputs the calculated remaining amount alert signal is less than the predetermined value. The drug solution administration device described.
  4.  前記演算部は、前記計算した前記残量アラート信号を出力する前記残量値が前記所定値未満のときには、前記残量スイッチの押下とは無関係に、基礎レート投与パターンに従って基礎レート投与を開始した時点から、前記薬液の残量のカウントを開始する、
     請求項2に記載の薬液投与装置。
    When the remaining amount value that outputs the calculated remaining amount alert signal is less than the predetermined value, the calculation unit starts the basal rate administration according to the basal rate administration pattern regardless of the pressing of the remaining amount switch. From the time point, start counting the remaining amount of the drug solution,
    The drug solution administration device according to claim 2.
  5.  前記報知部は、振動、音、表示又はこれらの併用により前記残量アラートを発する
     請求項1~4のいずれか一項に記載の薬液投与装置。
    The drug solution administration device according to claim 1, wherein the notification unit emits the remaining amount alert by vibration, sound, display, or a combination thereof.
  6.  前記筒体内を移動するプランジャの移動量をカウントするカウンタ部を設け、
     前記演算部は、前記カウンタ部がカウントした前記プランジャの移動量から前記薬液の残量をカウントする
     請求項1~5のいずれか一項に記載の薬液投与装置。
    A counter unit for counting the amount of movement of the plunger moving in the cylinder is provided,
    The drug solution administration device according to any one of claims 1 to 5, wherein the calculation unit counts the remaining amount of the drug solution from the movement amount of the plunger counted by the counter unit.
  7.  前記薬液を投与する基礎レート投与パターンが格納される記憶部を設け、
     前記演算部は、前記基礎レート投与パターンに基づいて、前記薬液の総投与量を計算する
     請求項1~6のいずれか一項に記載の薬液投与装置。
    A storage unit for storing a basal rate administration pattern for administering the drug solution is provided.
    7. The liquid medicine administration device according to claim 1, wherein the arithmetic unit calculates a total dose of the liquid medicine based on the basal rate administration pattern.
  8.  筒体内の薬液の残量が所定値になったときに残量アラートを発する薬液投与方法であって、
     前記薬液の総投与量から残量アラートを発する前記薬液の残量値を演算部により計算するステップと、
     前記残量アラートを発する残量値が前記所定値以上のときは、前記薬液の残量が前記所定値になったときに残量アラート信号を前記演算部により出力するステップと、
     前記残量アラートを発する残量値が前記所定値未満のときは、前記薬液の残量が前記所定値になったときに前記薬液の残量のカウントを前記演算部により開始するステップと、 前記カウントの値が前記残量アラートを発する前記残量値になったときに、残量アラート信号を前記演算部により出力するステップと、
     を含む薬液投与方法。
    A method for administering a liquid medicine that issues a remaining amount alert when the remaining amount of liquid medicine in the cylinder reaches a predetermined value,
    A step of calculating a remaining amount value of the liquid medicine that issues a remaining amount alert from the total dose of the liquid medicine by a calculation unit;
    When the remaining amount value for issuing the remaining amount alert is equal to or more than the predetermined value, a step of outputting a remaining amount alert signal by the computing unit when the remaining amount of the chemical liquid reaches the predetermined value,
    When the remaining amount value for issuing the remaining amount alert is less than the predetermined value, when the remaining amount of the chemical liquid reaches the predetermined value, the step of starting the counting of the remaining amount of the chemical liquid by the calculation unit, When the count value reaches the remaining amount value for issuing the remaining amount alert, outputting a remaining amount alert signal by the calculation unit,
    A method for administering a liquid medicine containing:
PCT/JP2019/025685 2019-02-15 2019-06-27 Liquid medicine administration device and liquid medicine administration method WO2020166102A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020572069A JP7299929B2 (en) 2019-02-15 2019-06-27 Chemical-solution administration device and chemical-solution administration method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019025049 2019-02-15
JP2019-025049 2019-02-15

Publications (1)

Publication Number Publication Date
WO2020166102A1 true WO2020166102A1 (en) 2020-08-20

Family

ID=72044899

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/025685 WO2020166102A1 (en) 2019-02-15 2019-06-27 Liquid medicine administration device and liquid medicine administration method

Country Status (2)

Country Link
JP (1) JP7299929B2 (en)
WO (1) WO2020166102A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006034719A (en) * 2004-07-28 2006-02-09 Terumo Corp Syringe pump, and transfusion method by syringe pump
US20120191058A1 (en) * 2011-01-24 2012-07-26 Alltek Marine Electronics Corp. Apparatus for Detecting Liquid Level, Remaining Liquid Quantity and Dripping Speed of Container
US20150061876A1 (en) * 2013-08-30 2015-03-05 Yi-Sheng Chang Warning Device For Infusion Apparatus
JP2015198864A (en) * 2014-04-10 2015-11-12 セイコーエプソン株式会社 Fluid injection device
WO2016132937A1 (en) * 2015-02-20 2016-08-25 テルモ株式会社 Liquid drug administration device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006034719A (en) * 2004-07-28 2006-02-09 Terumo Corp Syringe pump, and transfusion method by syringe pump
US20120191058A1 (en) * 2011-01-24 2012-07-26 Alltek Marine Electronics Corp. Apparatus for Detecting Liquid Level, Remaining Liquid Quantity and Dripping Speed of Container
US20150061876A1 (en) * 2013-08-30 2015-03-05 Yi-Sheng Chang Warning Device For Infusion Apparatus
JP2015198864A (en) * 2014-04-10 2015-11-12 セイコーエプソン株式会社 Fluid injection device
WO2016132937A1 (en) * 2015-02-20 2016-08-25 テルモ株式会社 Liquid drug administration device

Also Published As

Publication number Publication date
JP7299929B2 (en) 2023-06-28
JPWO2020166102A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
JP5461368B2 (en) Drug cartridge having identification means
JP4847678B2 (en) Improvements related to drug injection devices
JP5666560B2 (en) Pen syringe with ergonomic button arrangement
JPH06261942A (en) Automatic injection pump of which memory cartridge is replaceable
JP6640827B2 (en) Drug administration device
BR112018001018B1 (en) AEROSOL RELEASE UNIT
JP2018500965A (en) Drug delivery device with air safety mechanism in cartridge
JP7235745B2 (en) Control of medical devices using wireless communication
WO2020166102A1 (en) Liquid medicine administration device and liquid medicine administration method
JP2018157966A (en) Liquid medicine administration device
WO2020170478A1 (en) Liquid medicine administration device
JP6438822B2 (en) Chemical solution administration device
JP4358614B2 (en) Electric injection device
WO2023132103A1 (en) Medicinal solution administration device, control method thereof, and medicinal solution administration system
WO2010125153A1 (en) Pen-type injector with ergonomic button arrangement
CN111050824B (en) Liquid medicine administration device
JP3378054B2 (en) Drive control method for peristaltic infusion pump
JP2015181555A (en) Liquid feed pump

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19915144

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2020572069

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19915144

Country of ref document: EP

Kind code of ref document: A1